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4 ABSTRACT 
 
 
ESCRT (Endosomal Sorting Complex Required for Transport) proteins regulate cell surface 
receptor degradation by sorting and packaging ubiquitinated cargoes into the intraluminal vesicles 
of multivesicular bodies (MVBs). A range of human diseases including cancer, and 
neurodegeneration display altered expression or are caused by mutations of ESCRT subunits. 
Studies have shown that Drosophila tissues lacking ESCRTs display neoplastic-like features like 
overproliferation and polarity defects, partly due to aberrant signalling including Notch 
signalling. To understand ESCRT-regulated processes in vivo, we utilised modification of a 
deformed wing phenotype specifically caused by knockdown (RNAi) of Vps25, an ESCRT-II 
subunit. We systematically screened chromosomal regions and identified 204 genetic interactors 
of Vps25 that enhanced/suppressed the phenotype. They include genes that function in 
trafficking, signalling, transcription, ion transport and many other biological processes; 
suggesting that ESCRTs influence a wide range of biological processes. We have focused on a 
subset of these hits that regulate tissue growth with a secondary screen based on modification of a 
Delta-driven eye overgrowth phenotype, isolating a subset of 43 genes involved in regulating 
tissue growth, some of which are novel and uncharacterised. Human orthologues of some of these 
genes are important in cancers; dropout (dop), whose mammalian orthologues are the MAST 
kinases, have been shown to contribute towards breast cancer development. dop mediates Delta-
driven eye overgrowth possibly by upregulating Delta expression. In human cells, MAST2 does 
not affect Notch signalling but might contribute to tumorigenesis by regulating the NFκB 
pathway. We have also characterised another interactor, CG12163 which is the homologue of 
mammalian Cathepsin F. Mutations in Cathepsin F cause a rare form of neuronal ceroid 
lipofuscinosis (NCL) called Type B Kufs disease. Our Drosophila model which recapitulates 
aspects of the human disease phenotype suggests that defects in autophagy might underlie the 
pathogenesis of NCLs. 
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5 INTRODUCTION 
 
One of the defining features of eukaryotic cells is compartmentalization, that is, the formation 
of cellular organelles surrounded by membranes. It is thought to have propelled life towards 
multi-cellularity and emergence of a nervous system (Cavalier-Smith, 2002; Dacks and Field, 
2007). Most of the cellular logistics, which involves incessant trafficking of countless cargoes 
and associated macromolecules, are enabled by the plasma membrane and endo-membrane 
system. This process is crucial for cell fate and identity, as well as cell communication. 
5.1 Discovery and organisation of the ESCRT machinery 
 
The ESCRT machinery was first identified in yeast by genetic isolation of mutants that cause 
defective protein sorting to the vacuole, the functional equivalent of the lysosome (Bankaitis 
et al., 1986; Rothman et al., 1989). These mutants possessed enlarged pre-vacuolar endosome-
like compartments containing undegraded proteins, and were called ‘class E-vps mutants’ 
(Raymond et al., 1992). Most of the class E-vps genes were later found to act in succession to 
concentrate trafficking cargoes and include them into forming late endosomes (also termed 
multivesicular bodies or MVBs) that eventually fuse with lysosomes for degradation 
(Katzmann et al., 2001). The ESCRT machinery that regulates endosomal sorting is organized 
into five distinct protein complexes: ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III and the Vps4 
AAA-ATPase complex (see Table 1 for subunit compositions).  
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Table 1: Composition of the ESCRT complexes in endosomal sorting 
Complex Function Evolutionary 
origin 
Yeast Drosophila Human 
ESCRT-0 Cargo 
recognition 
Opisthokonta Vps27 Hrs HRS 
   Hse1 Stam STAM1, STAM2 
      
ESCRT-I Upstream 
adapter 
Eukaryotes Vps23 Tsg101 TSG101 
   Vps37  VPS37A, B, C, D 
   Mvb12 Mvb12 MVB12A, MVB12B 
   Vps28 Vps28 VPS28 
      
ESCRT-II Bridging 
adapter 
 Vps36 Vps36 EAP45 
   Vs22(Snf8) Vps22 EAP30 
   Vps25 Vps25 EAP20 
      
ESCRT-III Membrane 
remodeling/ 
filament 
Archaea 
 
Vps2 Vps2 CHMP2A, B 
   Vps24 Vps24 CHMP3 
   Vps32 (Snf7) Vps32 (Shrub) CHMP4A, B, C 
   Vps20 Vps20 VPS20/CHMP6 
   Vps46 (Did2) Chmp1 CHMP1A, B 
   Vps60 (Chm5) Chmp5 CHMP5 
      
Vps4 –Vta1 Membrane 
remodeling/ 
ATPase 
 Vps4 Vps4 VPS4A, B (SKD1, 2) 
   Vta1 CG7967 VTA1 (LIP5) 
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Figure 1: The ESCRTs in MVB biogenesis and receptor sorting. ESCRT-0, -I and -II 
interact with ubiquitinated cargo through their ubiquitin-binding domains, and sort them into 
intraluminal vesicles (ILVs). ESCRT-II recruits ESCRT-III to pinch/sever the ILV from the 
limiting MVB membrane. ESCRT-III polymeric filaments are responsible for the ILV 
abscission. The receptor is deubiquitinated before ILV formation. The Vps4 ATPase complex 
then disassembles the ESCRT-III complex for subsequent rounds of sorting. Adapted from 
(Rusten et al., 2012) 
 
 
 
5.2 Mechanism of ESCRT function in endosomal sorting 
During sorting, the ESCRT complexes are recruited sequentially from the cytoplasm to the 
endosomal membrane by interaction of specific subunits (Figure 1). Ubiquitination of cargoes 
provides the key signal for initial cargo binding by ESCRT-0 (see for review (Urbé, 2005)). 
Indeed, the ESCRT-0 subunits Hrs and Stam, as well as the ESCRT-I Vps23/Tsg101 and the 
ESCRT-II Vps36, all contain ubiquitin-binding domains that interact with ubiquitinated 
cargoes. ESCRT-0 is also recruited by interaction between the FYVE domain of Hrs and 
phosphatidylinositol 3-phosphate (PI3P), which is enriched at the endosomal membrane. 
ESCRT-0 is thought to concentrate ubiquitinated cargoes by organizing flat coats of clathrin 
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on the endosomal membrane (Raiborg et al., 2001, 2002). ESCRT-0 also summons ESCRT-I 
that retains the cargoes by ubiquitin binding and hands them to the ESCRT–II complex. The 
ESCRT-II complex provides a scaffold for the formation of the ESCRT-III complex, the 
business end of the ESCRT machinery. The Vps32/Snf7/Chmp4 subunit of ESCRT-III forms 
multimeric filaments organized in spirals that bend the endosomal membrane away from the 
cytoplasm to form invaginated buds. Thus, the combined activity of ESCRTs allows sorted 
cargoes to be corralled and trapped in nascent intraluminal vesicles (ILVs) of the MVBs that 
eventually pinch off into the endosomal lumen. The deubiquitinating enzyme Doa4 is recruited 
by ESCRT-III to remove ubiquitin from cargoes that are included into ILVs. Finally, the Vps4 
ATPase complex binds and fully unfolds the ESCRT-III complex in an ATP-dependent manner 
and favors pinching off the ILV neck, the final step of MVB biogenesis (Adell et al., 2014; 
Bache et al., 2003; Henne et al., 2012; Mageswaran et al., 2014; Malerød and Stenmark, 2009; 
Shields et al., 2009; Teis et al., 2010; Wollert and Hurley, 2010; Yang et al., 2015). The 
structure of most ESCRT components has been determined and detailed extensive knowledge 
of the ESCRT mechanism of action in endosomal sorting and MVB biogenesis is available (see 
for review (Hurley, 2010; Williams and Urbé, 2007)). 
 
5.3 ESCRTs activity during trafficking processes distinct from endosomal sorting 
The ESCRT-I, II, III and the Vps4 complexes are conserved across the eukaryotic lineage 
(Wideman et al., 2014). In contrast, the ESCRT-0 is present only in subset of eukaryotes. This 
indicated early on that they are specialized to couple the core membrane-remodeling activity 
of ESCRT-III and Vps4 with cargo sorting. Indeed, evidence indicates that additional 
complexes, such as those containing the protein Tom1, might control initial concentration of 
ubiquitinated cargoes in endosomes (Blanc et al., 2009). Consistent with the accessory role of 
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ESCRT-0, a large body of studies in the last 25 years revealed that the function of the ESCRTs 
at membranes is not limited to endosomal sorting and MVB biogenesis (Figure 2). 
 
Figure 2: Summary of ESCRT-dependent processes. In addition to the well-known role of 
ESCRTs in receptor sorting and MVB biogenesis, several processes have been shown to 
require the function of ESCRT proteins. Specific factors required for each process are written 
in italics. (Alfred and Vaccari, 2016). 
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5.3.1 ESCRTs and membrane budding 
Early work indicated that a number of viruses can recruit ESCRT-III and Vps4 to bud from 
the plasma membrane (Garrus et al., 2001; Pornillos et al., 2002), leading to subsequent 
realization that budding of the plasma membrane operated by ESCRTs occurs also in non-
infected cells to form ectovesicles. MVBs can also fuse to the plasma membrane to release of 
ILVs, in this case referred to as exosomes. As in endosomal sorting, deployment of ESCRT-
III and Vps4 in exosome and ectovesicle (together referred to as exovesicles) formation appears 
to depend either on the ESCRT-I and –II, or on Alix, and to require adapters different from the 
ESCRT-0. These data indicated that MVB and exovesicle biogenesis can profoundly differ and 
that multiple pathways of exovesicle formation are likely to exist (Baietti et al., 2012; 
Choudhuri et al., 2014; Colombo et al., 2013; MacDonald et al., 2015; Nabhan et al., 2012; 
Wehman et al., 2011) 
5.3.2 ESCRTs and autophagy 
MVBs also act as main stations for autophagic trafficking (Kaur and Debnath, 2015; Lamb et 
al., 2013). Evidences from Caenorhabditis elegans, Drosophila and mammalian cell in culture 
revealed that ESCRTs are required both for micro-autophagy and macro-autophagy (Morelli 
et al., 2014; Roudier et al., 2005; Rusten et al., 2007; Sahu et al., 2011). During 
macroautophagy, autophagosomes that are formed de novo to clear long-lived proteins, 
cytoplasmic aggregates or damaged organelles fuse to MVBs and lysosomes to form 
amphisomes and autolysosomes respectively, in which content is progressively degraded. 
While it recently emerged that ESCRT activity is coordinated with macroautophagic response 
to starvation (Jones et al., 2012; Müller et al., 2015), how ESCRT regulate autophagy 
mechanistically is currently unclear.  In summary, the membrane trafficking functions 
regulated by ESCRTs are crucial for lysosome-mediated cargo degradation, for release of 
exovesicles and, perhaps indirectly, for autophagy. 
14 
 
5.4 Non-trafficking functions of ESCRTs 
5.4.1 ESCRTs and cytokinesis 
The first evidence of ESCRT functions that are independent of membrane trafficking indicated 
that ESCRT-III and Vps4 act at the plasma membrane to sever microtubules and release the 
midbody during cytokinesis. In this case, the recruitment is operated by the midbody protein 
Cep55, with ESCRT-III directly recruiting the microtubule severing protein Spastin. This 
activity is present also in Archea and plants, suggesting that it is ancient evolutionarily (Carlton 
and Martin-Serrano, 2007; Lindås et al., 2008; Samson and Bell, 2009). Very recent studies 
showed similar recruitment of Spastin during nuclear envelope reformation at the end of 
mitosis, albeit with a different recruitment system (Olmos et al., 2015; Vietri et al., 2015).  
5.4.2 ESCRTs function at the membrane 
The roles of ESCRTs at the nuclear membrane began to emerge with the recognition that 
ESCRTs are required for budding of the Epstein–Barr virus through the nuclear membrane 
(Lee et al., 2012). More recently, it was found the ESCRT machinery also restores membrane 
integrity upon nuclear pore and nuclear envelope damage (Olmos et al., 2015; Raab et al., 2016; 
Webster et al., 2014). These membrane repair functions of the ESCRT machinery are also 
observed at the plasma membrane (Jimenez et al., 2014) and a likely developmental counterpart 
of such activity has been observed in neuron remodeling. Indeed, ESCRTs have been shown 
to be required for membrane scission that occurs during neuron pruning (Loncle et al., 2015). 
ESCRT-dependent neuronal remodeling events were described previously in Drosophila 
development but had been attributed to endo-lysosomal trafficking of neuronal receptors 
(Issman-Zecharya and Schuldiner, 2014; Sweeney et al., 2006; Zhang et al., 2014). 
5.4.3 Less studied functions of ESCRTs 
Other less understood ESCRT functions include control of centrosome number during mitosis 
(Frost et al., 2012; Jin et al., 2005; Morita et al., 2010; Xie et al., 1998), transcriptional gene 
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regulation (Burgdorf et al., 2004; Kamura et al., 2001; Lin et al., 2013; Schmidt et al., 1999; 
Stauffer et al., 2001; Sun et al., 1999), RNA transport (Irion and St Johnston, 2007), and 
miRNA biogenesis (Gibbings et al., 2009; Lee et al., 2009b). The mechanistic details of these 
processes are unclear. While it is reasonable to think that bending of membranes away from 
the cytoplasm might be involved - which to date represents the shared topological feature of 
all well-characterized processes operated by ESCRT - ESCRTs could also possess 
moonlighting functions that do not involve membranes.  
 
5.5 ESCRTs, signalling and tissue architecture  
Because a number of signalling proteins are transmembrane or membrane- associated, 
endocytosis and trafficking to lysosomes are crucial to regulate signal transduction (see for 
review (Sigismund et al., 2012)). Indeed, studies in cells of multicellular organisms that 
followed the initial discovery of ESCRT in yeast revealed that endosomal sorting complexes 
are essential to downregulate signalling, most prominently Epidermal Growth Factor (EGF)-
stimulated signalling (Babst et al., 2000; Bache et al., 2004, 2006; Baldys and Raymond, 2009; 
Bishop et al., 2002; Chanut-Delalande et al., 2010; Doyotte et al., 2005; Jékely and Rørth, 
2003; Lloyd et al., 2002).  
5.5.1 ESCRTs and Notch signalling 
5.5.1.1 Notch signalling 
An additional signalling pathway that is well known to be regulated by ESCRTs is that 
controlled by Notch receptors. Core components of the Notch pathway take part in so-called 
canonical signalling events initiated by interaction of Delta/Serrate/Lag2 (DSL) ligands - 
expressed by signal-sending cells - with the Notch receptor at the plasma membrane of 
receiving cells. Canonical signalling requires emergence to the plasma membrane of Notch as 
a heavily glycosylated heterodimer. Such modifications and cleavage operated by the serine 
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protease Furin (also called S1 cleavage) occur in the Golgi apparatus. Binding of DSL ligands 
in trans is thought to displace the extracellular domain of Notch, which is held in place by Ca2+ 
interactions. Shedding of extracellular Notch requires endocytosis of the ligand in the signal-
sending cell. It has been proposed that the Notch receptor is deformed by the pulling forces of 
the endocytosis in such a way to reveal a site for cleavage by metalloproteases (called S2 
cleavage). Metalloproteases cleavage turns Notch into a substrate for a final cleavage (S3 
cleavage) by the γ-secretase complex on the cytoplasmic side of the plasma membrane (Figure 
3).  
As Notch molecules are constitutively targeted to lysosomes for ubiquitin-dependent 
degradation, cleavage events during canonical signalling are likely to occur also on the 
endosomal membrane. In all cases of canonical signalling, once the intracellular domain of 
Notch (NICD) is liberated from membranes, it accesses the nucleus where it regulates 
transcription of target genes by de-repressing the CBF1/Su(H)/Lag-1 (CSL) [RBP-Jκ in 
mammals, Su(H) in Drosophila] transcription complex (Figure 3). Signal termination is 
ensured by ubiquitin-dependent proteasomal degradation of NICD [see for review (Bray, 
2016)]. 
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Figure 3: Canonical Notch Signalling Pathway. (A) Notch is cleaved to NICD by γ-
secretase at the plasma membrane, or en-route to endosomes, upon trans-activation by a DSL 
ligand expressed in signal-sending cells. Extracellular cleavage by ADAM metallo-proteases 
is a prerequisite for γ- secretase processing. (B) Target gene expression depends on CSL-
mediated transcription derepressed by NICD. (C) After ubiquitination by a number of E3-
ligases, such pool is internalized to endosomes. (D) Once in endosomes, Notch can be 
recycled back to the plasma membrane. (E) Alternatively, it is sorted to internal vescicles of 
the endosomes by ESCRTs and Lgd and eventually degraded in the lysosome. (F) A large 
pool of Notch is kept inactive by cisinhibition by DSL ligands. (Alfred and Vaccari, 
2018[accepted]). 
 
 
5.5.1.2 Mechanisms of ligand-independent Notch signalling 
One of the first modifiers of Notch that appeared to act independently of ligands is the product 
of the Drosophila deltex (dx) gene. dx encodes a cytoplasmic RING domain-containing protein, 
called dx, that binds to the Ankyrin repeats of the Notch intracellular domain (Busseau et al., 
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1994; Diederich et al., 1994; Matsuno et al., 1995; Xu and Artavanis-Tsakonas, 1990). Indeed, 
ectopic activation of Notch signalling could be achieved by dx overexpression in Drosophila 
wing margin cells that lacked both Delta (Dl) and Serrate ligands. dx generally functions as a 
positive regulator of Notch signalling because dx mutants suppress Notch gain-of-function 
wing phenotypes (Hori et al., 2004). Molecularly, dx was found to facilitate Notch mono-
ubiquitination and re-localization from the cell surface towards the late endosome (LE). It also 
retains Notch on the LE limiting membrane, possibly favouring ectodomain shedding in the 
endosomal environment. By depleting Notch from the cell surface, dx reduces the pool of 
receptors accessible to ligands; however, by retaining Notch on the LE surface, dx prevents 
some Notch receptors from degradation in lysosomes, making them available for signalling 
(Hori et al., 2004, 2011; Wilkin et al., 2008; Yamada et al., 2011). In addition, when complexed 
with kurtz (krz), a non-visual -arrestin identified as the first dx physical interactor, dx 
attenuates Notch signalling. The binding of dx-krz complex to Notch promotes the 
polyubiquitination of endocytosed Notch receptors leading to their degradation. This requires 
the presence of shrub (Charged Multivesicular Body Protein 4 [CHMP4] in mammals), a 
subunit of the Endosomal Sorting Complex Required for Transport (ESCRT)-III that directs 
cargoes towards the intraluminal vesicles of LEs (Hori et al., 2011; Mukherjee et al., 2005)]. 
Blocking the trafficking of Notch receptors towards LEs by mutations of Rab5, Rab7, AP-3 
and HOPS complex genes inhibited dx-mediated Notch activation suggesting that ligand-
independent Notch signalling requires Notch receptors to be localized to the LE limiting 
membrane (Vaccari et al., 2008; Wilkin et al., 2008; Zheng et al., 2013). Consistent with the 
fact that dx mostly affects ligand-independent signalling, ectopic Notch signalling in 
Drosophila ESCRT mutant tissues is not abolished by mutations that block ligand activity 
(Vaccari et al., 2008).  Mechanisms of ligand-independent Notch signalling are summarised in 
Figure 4. 
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Figure 4: Non-canonical Notch signalling. (A) A pool of Notch can be activated in a 
ligand-independent fashion (B) Such pool of internalized Notch can be saved from 
endosomal sorting towards degradation by the activity of the E3 –ligase dx, and cleaved at 
the endosome, or upon fusion with the lysosome. β-arrestin, ESCRTs and other factors 
participate in the process. (C) Cis-inhibition prevents inappropriate ligand-independent 
activation. (D) In some cases this pathway can result in target gene expression that is CSL-
independent. Inhibition of signaling can be achieved by direct binding to the apical 
determinant crb, or to Dvl, a Wnt signalling component (E). The level of a second Wnt 
component, β-catenin (β-cat), which also binds to Notch, is downregulated by endosomal 
sorting, thus preventing excess Wnt signaling. (F) Notch activation is inhibited by Akt 
signaling by directly binding the component PI3K, possibly in the endosomal system. (Alfred 
and Vaccari, 2018[accepted]). 
 
Drosophila Suppressor of Deltex [Su(dx)] mutants dominantly suppress the phenotypes 
of dx mutants, hence the name. Su(dx), which encodes a Homologous to the E6-AP Carboxyl 
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Terminus (HECT)-type E3 ubiquitin ligase of the Neural precursor cell expressed 
developmentally down-regulated protein 4 (Nedd4) family, has been described as a negative 
regulator of the Notch pathway by antagonizing Deltex and Notch (Busseau et al., 1994; 
Cornell et al., 1999; Fostier et al., 1998; Mazaleyrat et al., 2003). Su(dx) transiently interacts 
with Notch at the cell surface and subsequently sorts constitutively-internalized full-length 
Notch receptors away from the Rab11-positive recycling endosome and into an 
ESCRT/ubiquitin-positive compartment for degradation to downregulate signalling (Djiane et 
al., 2011; Wilkin et al., 2004). Su(dx) also counteracts ligand-independent Notch signalling by 
directly ubiquitinating Notch receptors. Drosophila Nedd4, a second HECT-domain E3 ligase, 
also reduces ligand-independent Notch signalling using similar mechanisms proposed for 
Su(dx) (Sakata et al., 2004). In addition, Drosophila Nedd4 family interacting protein (Ndfip) 
promotes ligand-independent Notch signalling using the same mechanism as dx (Dalton et al., 
2011). The mouse homolog of Su(dx), called Itchy E3 Ubiquitin Protein Ligase (Itch), also 
physically interacts with Notch, promotes its ubiquitination and degradation, and subsequently 
downregulates Notch signalling (Qiu et al., 2000). Su(dx) may also antagonize Notch signalling 
by promoting the degradation of dx. Indeed, Atrophin-1 Interacting Protein 4 (AIP4), the 
human Su(dx) homolog, directly binds dx to promote its polyubiquitination and subsequent 
degradation (Chastagner et al., 2006). 
Ligand-independent signalling in Drosophila is also prevented by lethal (2) giant discs 
(lgd) which was originally classified as a tumor suppressor gene because its deletion caused 
overproliferation of larval epithelial imaginal discs, eventually found to be due to ectopic 
activation of Notch signalling (Bryant and Schubiger, 1971; Watson et al., 1994)]. lgd encodes 
a C2-domain containing protein that binds phospholipids and interacts with the ESCRT-III 
subunit shrub. Analysis of lgd mutant tissues suggests that lgd functions in endosomal sorting 
towards degradation and that defects in lgd ultimately reduce shrub function, causing Notch 
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receptors to accumulate on the limiting membrane of LEs and ectopically signal, even in 
absence of ligands. Importantly, such activation depends on the cleavage of Notch by the γ-
secretase complex and requires fusion of LEs with lysosomes (Childress et al., 2006; Gallagher 
and Knoblich, 2006; Jaekel and Klein, 2006; Klein, 2003; Schneider et al., 2013; Troost et al., 
2012). This suggests that that Ca2+ release associated with fusion events, or protein degradation 
in the lysosomal lumen, could substitute for ligands in shedding the extracellular part of the 
Notch heterodimer. lgd regulation of ESCRT activity might extend beyond Notch. Indeed, 
Drosophila lgd mutants display ectopic activation of the BMP/Dpp signalling receptor 
Thickveins (Morawa et al., 2015).  
Human lgd homologs Coiled-Coil And C2 Domain Containing 1A (CC2D1)A/B also 
play important roles in endosomal sorting by interacting with and regulating the ESCRT-III 
subunit CHMP4. However, CC2D1A and CC2D1B mutants do not display marked differences 
in Notch signalling (Drusenheimer et al., 2015; Martinelli et al., 2012; Usami et al., 2012). 
This, together with the evidence that human lgd paralogs also control Nuclear Factor Kappa B 
(NF-κB) and Epidermal Growth Factor Receptor (EGFR) signalling (Deshar et al., 2016; Zhao 
et al., 2010), indicates that aspects of endocytic ligand-independent Notch activation in human 
cells might differ from the Drosophila paradigm.  
 
5.5.1.3 ESCRT and ligand-independent Notch signalling 
Drosophila mosaic animals indicate that ESCRT function is required to regulate Notch 
signalling, which drives multiple cell fate decisions. Drosophila organs developing in absence 
of ESCRT-I, -II, -III activity display increased, and for the most part ligand-independent, Notch 
signalling activity, due to accumulation of Notch receptors that fail to be included into MVBs 
on the limiting membrane of endosomes. Signal activation does not require ligands because it 
still occur when ligands Delta and Serrate are impaired genetically (Herz et al., 2006; Moberg 
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et al., 2005a; Thompson et al., 2005; Vaccari and Bilder, 2005; Vaccari et al., 2009). Despite 
endosomal Notch accumulation, ESCRT-0 mutant organs of mosaic animals do not show 
ectopic Notch signalling activity (Jékely and Rørth, 2003; Lloyd et al., 2002; Tognon et al., 
2014), highlighting differences in regulation of Notch signalling by distinct endosomal sorting 
components.  
5.5.2 ESCRTs and other signalling pathways 
Analysis of mouse ESCRT knock-outs revealed a requirement for cell survival, proliferation 
and signalling regulation leading to lethality early during embryogenesis (Komada and 
Soriano, 1999; Ruland et al., 2001; Shim et al., 2006; Yamada et al., 2002). Interestingly, a 
mouse hypomorph mutant of Vps25, encoding a ESCRT-II component, allows development to 
occur and reveals a specific requirement for ESCRTs in downregulating Sonic Hedgehog and 
FGF(fibroblast growth factor) signalling during limb development (Handschuh et al., 2014). 
Several other signalling pathways have been shown to be deregulated when ESCRT function 
is impaired in multiple model systems. These include JNK (Jun amino-terminal kinases), 
JAK/STAT (Janus kinase/signal transducer and activator of transcription), Hedgehog, Wnt, 
FGF, Toll, NFkβ and TGF-β (transforming growth factor) signalling (Handschuh et al., 2014; 
Huang et al., 2010; Jékely and Rørth, 2003; Lund and Delotto, 2011; Mamińska et al., 2016; 
Matusek et al., 2014; Moberg et al., 2005a; Rodahl et al., 2009; Seto and Bellen, 2006; Shim 
et al., 2006; Taelman et al., 2010; Woodfield et al., 2013a). 
5.5.3 ESCRTs, cell polarity and apoptosis 
In ESCRT mutant Drosophila tissues, cell polarization is impaired, likely because a number of 
polarity determinants require endosomal trafficking to be maintained at correct levels to 
polarize membranes and cell-cell junctions (Dukes et al., 2011; Gilbert et al., 2009; Leithe et 
al., 2009; Lobert and Stenmark, 2011; Palacios et al., 2005). Apoptotic response is enhanced 
as well. However, it is not clear whether this is an indirect consequence of the signalling and 
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polarity defects (Herz et al., 2006, 2009; Woodfield et al., 2013a). Ectopic activation of 
signalling and altered cell polarity contribute to formation of tumor-like tissue in epithelial 
organs of Drosophila lacking ESCRT-I, -II, -III components, that are highly over proliferative, 
especially when apoptosis is inhibited. These traits led to the proposal that ESCRT genes act 
as tumor suppressors in metazoans (reviewed in (Vaccari and Bilder, 2009)). Drosophila 
ESCRT-0 genes, however, do not behave as tumor suppressors, perhaps reflecting the distinct 
evolutionary origin of the complex or redundancy with other cargo-recruiting molecules like 
TOM1 or GGA proteins (Tognon et al., 2014). 
Overall, development and cell biology studies in multicellular organisms reveal that ESCRTs 
play essential and pleiotropic functions that impact deeply tissue formation and homeostasis.   
 
5.6 Roles of ESCRTs in human pathology 
5.6.1 ESCRTs and cancer 
Misexpression of ESCRT subunits has been associated with several types of human cancers. 
However, the role of ESCRT in tumorigenesis remains highly controversial. One of the most 
studied ESCRT in this regard is the ESCRT-I gene TSG101, which was initially isolated in a 
search for novel tumor suppressor genes (the acronym stands for Tumor Susceptibility Gene 
101). Inactivation of TSG101 in NIH3T3 cells gave rise to metastatic tumors when xenografted 
in nude mice (Li and Cohen, 1996). Consistent with this, TSG101 expression is significantly 
downregulated in cervical carcinomas (Broniarczyk et al., 2010). Despite this, the role of 
TSG101 as a tumor suppressor has been debated, because it was later found that conditional 
knock-out of Tsg101 in mouse mammary epithelia did not promote tumor formation but instead 
arrested cell growth (Krempler et al., 2002; Wagner et al., 2003). Although TSG101 expression 
seems tightly regulated by an active mechanism (Feng et al., 2000), a study evaluating the 
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effect of TSG101 overexpression indicated that tumor maintenance and progression, rather than 
initiation, might benefit from higher levels of TSG101 (Oh et al., 2007). Despite this, the gene 
has been found significantly overexpressed also in lung cancer (Liu et al., 2010), gallbladder 
adenocarcinoma (Liu et al., 2011), papillary thyroid tumors (Liu et al., 2002b) and ovarian 
carcinomas (Young et al., 2007a). These tumors might be addicted to high levels of TSG101, 
as its depletion was shown to reduce tumor growth, to slow tumor migration, to halt cell cycle 
progression and to trigger apoptosis of cancer cells (Young et al., 2007b; Zhang et al., 2011; 
Zhui et al., 2004). TSG101 appears also to be a prognostic marker in some cancers because its 
high expression correlates with poor prognosis, decreased survival, high tumor stage, increased 
metastasis and invasion (Liu et al., 2011; Young et al., 2007b). 
Besides TSG101, another ESCRT-I gene, VPS37A, was identified because of its down-
regulation in hepatocellular carcinomas (HCC) and named HCRP1 (human hepatocellular 
protein 1) accordingly (Bache et al., 2004; Xu et al., 2003). Reduced VPS37A/HCRP1 
expression strongly correlates with depth of tumor invasion, lower survival and higher rate of 
disease recurrence not only in hepatocellular carcinoma, but also in breast cancer, renal cell 
carcinoma, oral and oropharyngeal cancers (Chen et al., 2015; Lai et al., 2009; Wittinger et al., 
2011; Xu et al., 2014, 2003). Most of the effect of VPS37A loss has been attributed to reduced 
EGF receptor degradation (Bache et al., 2004; Wittinger et al., 2011), activation of downstream 
MAPK/ERK signalling and increased matrix metalloproteinase-2 (MMP2) expression: the loss 
of VPS37A has been proposed to increase tumor proliferation and invasion, and in ovarian 
cancer patients to lower response to cetuximab treatment (Wittinger et al., 2011; Xu et al., 
2003). 
Several subunits of the human ESCRT-III and Vps4 complexes have been also linked to tumor 
development. CHMP1A appears significantly downregulated in renal cell carcinomas (You et 
al., 2012) and pancreatic tumors (Li et al., 2008; Mochida et al., 2012), in which it has been 
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proposed to function as a tumor suppressor. Accordingly, non-tumorigenic human embryonic 
kidney cells acquire the ability to form xenograft tumors when CHMP1A is depleted (Mochida 
et al., 2012). CHMP1A overexpression inhibits the proliferation of renal (You et al., 2012) and 
pancreatic tumor cells (Mochida et al., 2012). CHMP1A appears to inhibit tumor growth in the 
pancreas by regulating the activation of ATM (ataxia telangiectasia mutated) kinase and 
phosphorylation of p53 (Li et al., 2008; Mochida et al., 2012). Recent reports have identified a 
strong upregulation (and correlation with poor prognosis) of CHMP4B in hepatocellular 
carcinoma, and have suggested that CHMP4B and CHMP4C might be required to sustain 
proliferation and resistance to anti-cancer treatment in human hepatocellular and lung cancer 
cell lines, respectively (Hu et al., 2015; Li et al., 2015). In a study aimed at characterizing 
miRNAs in exosomes of hepatocellular carcinoma cells, it was found that modulation of 
VPS4A changed exosome content and activity. Vps4A was also found to act as a tumor 
suppressor, by repressing the PI3K/Akt pathway (Wei et al., 2015). Other studies suggested 
that VPS4A and exosomes could influence resistance to cancer drugs like cisplatin and 
doxorubicin by modulating their efflux (Chen et al., 2006; Safaei et al., 2005). 
Finally, expression of the ESCRT-0 component HRS is significantly increased in human tumor 
tissues derived from the stomach, colon, liver, cervix and melanoma ― suggesting the 
existence of a tumor-enhancing function for HRS. Depletion of HRS reduced the 
tumorigenicity and metastatic ability of HeLa cells and upregulated the protein level of 
adherens junction component E-Cadherin (Toyoshima et al., 2007). Since HRS functions in 
the endolysosomal trafficking and degradation of E-Cadherin (Palacios et al., 2005; Toyoshima 
et al., 2007), it has been proposed that in these tumors the cargo sorting function of HRS is 
hijacked to downregulate E-cadherin and promote metastasis. Overall, the involvement of 
ESCRT in tumorigenesis is multifaceted and likely to be dependent on the tumor context, 
reflecting the complexity of the phenotypes observed in ESCRT mutant organs of Drosophila. 
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5.6.2 ESCRTs and neurodegeneration 
ESCRT loss is observed frequently in many neuropathologies. Among the best characterized 
are the form of autosomal dominant frontotemporal dementia (FTD) caused by mutations in 
CHMP2B, a subunit of ESCRT-III (Skibinski et al., 2005; van der Zee et al., 2008). The 
mutations lead to loss of the protein C-terminus, which controls autoinhibition and interaction 
with Vps4 (Lee et al., 2007; Obita et al., 2007; Stuchell-Brereton et al., 2007; Urwin et al., 
2010; Zamborlini et al., 2006). Accordingly, enlarged dysmorphic late endosomes have been 
found in cells of FTD patients (Nielsen et al., 2012; Skibinski et al., 2005). Similar endosomal 
phenotypes are observed when mutant CHMP2B is overexpressed in human cells (van der Zee 
et al., 2008). It has been proposed that mutant CHMP2B impairs endosome-to-lysosome fusion 
by blocking the endosomal recruitment of the GTPase Rab7, by inhibiting ESCRT-III 
dissociation from endosomes, or by preventing the disassembly of ESCRT-III complex. 
Defective autophagy is another mechanism by which CHMP2B mutations might cause FTD. 
Such scenario is suggested by the presence of ubiquitin inclusions positive for the autophagy 
marker p62, which are often observed upon failure of autophagic clearance (Cox et al., 2010; 
Holm et al., 2007; Lee and Dutta, 2009; Lee et al., 2007). Overall, the endo-lysosomal and 
autophagy defects are thought to lead to accumulation of protein aggregates, inducing neuronal 
degeneration, which is a hallmark of the disease. CHMP2B mutations have also been identified 
in amyotrophic lateral sclerosis (ALS) patients (Cox et al., 2010; Parkinson et al., 2006) 
suggesting that defective ESCRT activity may contribute also to ALS pathogenesis. 
Mutations in the microtubule severing protein Spastin, that has been found associated 
to the ESCRT-III complex during cytokinesis and nuclear membrane reformation, cause 
hereditary spastic paraplegia (HPS) (Reid et al., 2005). Spastin function in HPS has been linked 
to shaping of the endoplasmic reticulum (ER) (Park et al., 2010) and recently to formation of 
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lipid droplets (Papadopoulos et al., 2015). This indicates that either ESCRT-independent 
functions of Spastin are affected in HPS or that ESCRTs and Spastin might cooperate in 
membrane and microtubule remodeling at the ER or in lipid droplets. Underscoring this 
interesting possibility, mutations in VPS37 (ESCRT-I) have also been identified in HPS 
patients (Zivony-Elboum et al., 2012).  
While no mutations have been isolated so far, ESCRT-III function has also been 
reported to be important for aspects of Alzheimer’s disease (AD) and of Lewy Body Dementia 
(DLB, an umbrella term for two related diagnoses, Parkinson’s disease dementia and dementia 
with Lewy bodies). Lewy bodies are abnormal aggregates containing damaged alpha-synuclein 
(α-SYN) and other proteins, and α-SYN aggregation is a trait associated to the progression of 
Parkinson’s disease and DLB (Baba et al., 1998; Braak et al., 2003). A feature of Alzheimer’s 
disease and of DLB is the prion-like cell-to-cell spreading of α-SYN aggregates leading to 
rapid disease progression (Lee et al., 2011). According to recent studies, α-SYN aggregates are 
taken up by clathrin-mediated endocytosis, undergo ESCRT-mediated trafficking through 
MVBs, and are degraded in lysosomes (Alvarez-Erviti et al., 2011; Hasegawa et al., 2011; 
Spencer et al., 2016). Rapid clearance of α-SYN aggregates and amelioration of the 
neurodegenerative pathology was observed upon CHMP2B overexpression (Spencer et al., 
2014, 2016); on the other hand, siRNA-mediated depletion of CHMP2B increased the 
exocytosis and intercellular transmission of α-SYN aggregates (Spencer et al., 2016). In 
addition, α-SYN aggregates colocalized with Vps4 (Kurashige et al., 2013), and inhibition of 
Vps4 function using a dominant-negative construct blocked lysosome-mediated degradation 
and increased extracellular secretion of α-SYN, possibly by means of exosomes (Hasegawa et 
al., 2011). 
The formation of amyloid-beta (Aβ) aggregates in AD also appears to involve 
regulation by ESCRT proteins. In fact, it has been recently shown that Aβ and amyloid protein 
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precursor (APP) are sorted into the intraluminal vesicles of MVBs. Depletion of Hrs and 
Tsg101 increases the intracellular accumulation of Aβ by simultaneously inhibiting lysosomal 
delivery of APP and reduced Aβ secretion through a yet-unknown mechanism (Edgar et al., 
2015).  
Finally, early work showed that fluorescently-tagged polyglutamine aggregates of mutant 
Huntingtin protein required the function of ESCRT-III protein CHMP3/Vps24 for autophagic 
clearance (Filimonenko et al., 2007; Yamamoto et al., 2006). However, no follow-up has 
further detailed alterations of ESCRT activity in Huntington’s disease. 
 
5.6.3 ESCRTs and infection 
As introduced above, a number of pathogenic viruses including the human 
immunodeficiency virus-1 (HIV-1), the hepatitis C virus (HCV), and the Ebola virus (EBOV) 
hijack ESCRTs for their maturation and eventual budding to release infectious particles from 
infected cells. Indeed, plenty of data indicate that viral proteins, such as the Gag protein of 
HIV-1, recruit TSG101 and ALIX, which in turn recruit ESCRT-III and VPS4 proteins, to the 
neck of the viral particle assembling at the plasma membrane (Bleck et al., 2014; Corless et al., 
2010; Effantin et al., 2013; Van Engelenburg et al., 2014; Garrus et al., 2001; Jun et al., 2015; 
Prescher et al., 2015; Sandrin and Sundquist, 2013). In the absence of TSG101 and ALIX, 
HCV, Herpes simplex virus type 1 (HSV-1), and to some extent HIV-1, are still able to recruit 
ESCRT-III (Corless et al., 2010; Morita et al., 2011; Pawliczek and Crump, 2009) suggesting 
that additional proteins mediate these interactions. Alternatively, viral proteins may be able to 
recruit downstream ESCRT components; for instance the matrix protein VP40 of EBOV, in 
addition to recruiting TSG101, also directly recruits VPS4 along with some other ESCRT 
proteins to the site of budding (Silvestri et al., 2007).  
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In addition, a number of reports suggests that several viruses incorporate their proteins, 
mRNAs or microRNAs into exovesicles of their hosts to promote their spread, to modulate 
immunity, or to manipulate the microenvironment (Alenquer and Amorim, 2015; Kadiu et al., 
2012; Madison and Okeoma, 2015; Meckes et al., 2010; Narayanan et al., 2013; Pegtel et al., 
2010; Tamai et al., 2012; Temme et al., 2010). ESCRT activity is also required for entry of 
rotaviruses and human papilloma virus (HPV), as these are taken up by endocytosis, sorted into 
ILVs and eventually released in the cytoplasm (Broniarczyk et al., 2014; Garrison et al., 2013; 
Li and Blissard, 2012; Pasqual et al., 2011; Shtanko et al., 2014; Silva-Ayala et al., 2013; Simon 
et al., 2009). Finally, a role for ESCRT-II in the replication of HIV-1 has also been reported. 
In fact, depletion of ESCRT-II subunits in HIV-1-infected human HeLa cells affected the 
cytoplasmic trafficking of HIV-1 genomic RNA and reduced the expression of the HIV Gag 
protein (Ghoujal et al., 2012; Meng et al., 2015). Similar results were reported for the hepatitis 
B virus (HBV) (Stieler and Prange, 2014). Whether the function of ESCRT-II in this particular 
aspect of the viral life cycle corresponds to that in transport of endogenous mRNA in 
Drosophila (Irion and St Johnston, 2007) is currently unclear.  
Several non-viral pathogens also exploit the function of ESCRTs in infecting their 
hosts.  A genome-wide screen in Drosophila S2 and murine macrophage cells have identified 
that ESCRT components restrict the growth of mycobacteria by impairing phagosome 
maturation, raising the possibility that mycobacteria may disrupt host ESCRT function for their 
growth. Indeed, a protein secreted by Mycobacterium tuberculosis (which causes tuberculosis) 
binds to Hrs of ESCRT-I to hinder sorting towards the lysosome for degradation (Agaisse et 
al., 2005; Mehra et al., 2013; Philips et al., 2008). A subunit of anthrax lethal toxin secreted by 
Bacillus anthracis is packaged into ILVs of multivesicular endosomes of infected cells, both 
for longer half-life and for exosomal secretion (Abrami et al., 2013). Finally, Candida albicans, 
an opportunistic fungal pathogen that colonizes mucosal surfaces, requires ESCRT activity for 
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pathogenesis and colonization. In contrast to viruses and other pathogens that hijack the host 
ESCRT machinery, C. albicans uses its own ESCRT complex to adapt to the neutral-alkaline 
pH of the host environment (Cornet et al., 2005; Kullas et al., 2004; Wolf and Davis, 2010; 
Wolf et al., 2010; Xu et al., 2004; Zhang et al., 2015b). In summary, pathogens clearly exploit 
a wide-range of the diverse cell biologic functions of ESCRTs offering multiple points of entry 
for future innovative therapies. Overall these studies clearly suggest that defects in endosomal 
sorting, autophagy, exosome release and Spastin-dependent membrane remodeling, contribute 
to key aspects of the pathology of a broad range of neurodegenerative diseases and that future 
detailed understanding and modulation of ESCRT activity could provide a major therapeutic 
benefit. 
5.6.4 Other diseases linked to ESCRT function 
Mutations in the ESCRT-III subunit, CHMP4B, have been identified in progressive childhood 
posterior subcapsular cataracts (PCPSC) linked to chromosome 20q (Shiels et al., 2007). 
According to Sagona and colleagues, CHMP4B may protect eye lens from developing cataract 
by mediating the autophagolysosomal degradation of micronuclei during lens differentiation, 
or by ensuring efficient cytokinesis (Sagona et al., 2014). Intestinal epithelial cells (IECs) of 
patients with Crohn’s Disease, an inflammatory bowel disease, possess significantly 
upregulated Vps4B expression. This upregulation facilitates apoptosis of IECs by activating 
the MAPK signalling pathway (Zhang et al., 2015a).  
5.7 Aim of the work 
The aim of this study was to identify novel biological roles of ESCRT using Drosophila as a 
model due to its genetic tractability. Here, we focused on the ESCRT-II subunit, Vps25, 
because Drosophila epithelial tissues lacking Vps25 display tumour-like phenotypes 
including uncontrolled signaling, overproliferation and loss of apico-basal polarity (Herz et 
al., 2006; Thompson et al., 2005; Vaccari and Bilder, 2005; Woodfield et al., 2013b).  
31 
 
Objectives 
i. Define the set of genes that genetically interact with ESCRT-II subunit Vps25 and 
the range of biological processes that influence or are influenced by ESCRT 
function in epithelial tissue. 
ii. Identify those Vps25 interactors that also participate in tissue growth. 
iii. Characterize novel interactors, focusing on that might clarify the involvement of 
ESCRTs in cancer and neurodegeneration. 
Parts of this chapter may have been published before completion of the whole thesis 
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6 MATERIALS AND METHODS 
6.1 Fly strains, mapping, and genetics 
Flies were maintained on standard yeast/cornmeal/agar media. All experiments were 
performed at 25°C with dry yeast added to the surface. Other genetic markers and special 
chromosomes are described by FlyBase (FlyBase Consortium 2003). Deficiency kits, P-
element insertion lines and all mutant lines were obtained from the Bloomington Centre, 
unless otherwise stated. RNAi lines were obtained from either the Bloomington or Vienna 
Drosophila RNAi Centre (VDRC).  
 
6.2 Genetic screen 
The fly strain previously generated in the lab MS1096GAL4, UAS-Vps25RNAi#3/FM7 was 
used to set up crosses with deficiency lines. Within these deficiency regions, high-ranking 
mutant lines available in the stock centre were ordered and tested. RNAi or UAS-based 
strains were crossed to MS1096GAL4 driver alone to screen for non-specific effects on wing 
phenotypes. The size of the wing was used to determine the modification. Because, we 
observed a variability of 10% in the baseline wing phenotype, only deficiencies/mutants that 
modified the wing size by 20% or greater were considered. Adult flies were scored 2-3 days 
after eclosion and only females were considered due to the sex-based difference in size.  
More than 10 females from crosses displaying modification were collected in isopropanol and 
kept at -20ºC until preparation. Wings were dissected in isopropanol and mounted on 
microscopy slides using a mixture of Canadian balm (xylem-free) with methyl salicylate 1:1. 
Preps were dried at room temperature and analyzed and imaged with a Nikon SMZ1500 
microscope using the NCIS Elements 5.0 software. For the secondary screen, we generated 
the eyGAL4, UAS-Delta#2/CyO stock using standard genetic recombination procedures. 
Dop mutant stocks and UAS constructs were obtained from Arno Muller lab. 
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6.3 CRISPR/Cas9 mutagenesis 
For the design of guide RNAs we used the MIT CRISPR design tool (http://crispr.mit.edu/, 
Zhang Lab, MIT). We selected those gRNA sequences that had fewer predicted off-targets 
that fell on non-target chromosomes. To express Cas9 in Drosophila germ cells, we used a 
previously constructed pBFv-nos-Cas9 plasmid 140, containing the wild-type Cas9 coding 
sequence, 1264 base pairs of the nanos promoter, which has been shown to drive highly 
specific germline expression, and the nanos 3’UTR. The attB donor sequence for site-specific 
integration by the PhiC31 system, the ampicillin resistance cassette and the vermilion gene as 
an eye pigmentation marker are also included in the pBFvnos-Cas9 plasmid. The general 
sgRNA expression vector pBFv-U6.2 140, obtained from the NIG-Fly stock center, contains 
399 base pairs of the Drosophila snRNA:U6:96Ab gene promoter sequence and 81 base pairs 
of the sgRNA scaffold. The attB donor sequence, the vermilion marker and an ampicillin 
resistance cassette are also incorporated into the transformation vector. The sgRNA target 
sequences, selected as 20 nt sequences preceding a NGG PAM sequence in the genome, were 
inserted between two BbsI restriction sites at the beginning of the sgRNA scaffold and 
overhangs were added to allow ligation. The oligonucleotides used to construct the sgRNA 
vectors are as follows: 
 CG11876   F: 5’ CTTCGACCTGGAACTTCTCCATGC 3’ 
                                             R:         5’ AAACGCATGGAGAAGTTCCAGGTC 3’ 
 
               CG12163                  F: 5’ CTTCGTGAAGAATCAGGGATCCTG 3’ 
                                                 R: 5’ AAACCAGGATCCCTGATTCTTCAC 3’ 
 
               CG3764                    F: 5’ CTTCGCACAGCAGTACTTTCGTAC 3’ 
                                                 R:       5’ AAACGTACGAAAGTACTGCTGTGC 5’7 
 
                CG10147                 F:       5’ CTTCGGGCATGCGGTTTGTCTGCG 3’ 
 R:      3’ AAACCGCAGACAAACCGCATGCCC 5’ 
 
                Mkrn1                      F:      5’ CTTCGCTTGGAGTGCATTCGCACA 3’ 
                                                 R:     5’ AAACTGTGCGAATGCACTCCAAGC 3’ 
 
    CG32113                  F:      5’ CTTCGTGGGTGCTGAACACGTATC 3’ 
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                                                 R:     5’ AAACGATACGTGTTCACGACCCAC 3’ 
 
Plasmids containing gRNA were sent to Genetic Services Inc. to perform site-directed 
injections. All the constructs were injected into embryos for integration of sgRNA vector into 
the attP40 landing site on the second chromosome. 
The T7 E1 endonuclease assay was used to screen for indel mutants. Briefly, 15 µl from the 
50 µl total volume of PCR product was taken and transferred in new PCR 0,2ml eppendorf 
tube. The products of the PCR reaction were denatured and reannealed to facilitate the 
formation of heteroduplex between DNA strands. Then 10 µl from the reannealed PCR 
product was removed and transferred into a new eppendorf tube to start the digestion. In the 
same tube 2µl of 10X NEBbuffer 2 (provided by New England Biolabs), 0,25 µl of T7E1 and 
7,75 µl of nuclease free water were added reaching the total volume of 20µl. The sample was 
incubated for 20 minutes at 37°C. Then immediately 15 µl of the total volume was 
transferred into a new tube and 3 µl of 6X loading dye was added, the fragment analysis was 
concluded by loading the 18 µl volume on a 1.5% 1XTAE agarose gel. 
  
6.4 Lifespan and climbing assays 
For the lifespan experiments, 120 flies (unless otherwise stated) collected at day 1 of their 
lives were housed in groups of 20 and the flies were transferred every 2 days onto fresh food 
and the number of dead flies recorded. For oxidative stress treatments, hydrogen peroxide 
was mixed into the fly medium at a final concentration of 3%.  Groups of ten flies were 
placed in an empty climbing vial and then tapped down to the bottom. They were allowed for 
15 seconds to climb past a line marked 5 cm from the bottom of the vial. The number of flies 
above the 5-cm mark within 15 seconds was recorded as a percentage of flies able to climb 
the tube. The day before the assay, flies were transferred to a new food vial to help reduce 
wet food from inhibiting their climbing ability; moreover, flies were not exposed to CO2 at 
35 
 
least 24 hours before the assay, as carbon dioxide quickly anesthetizes the insects. The 
climbing assay was performed on minimum of 30 flies per genotype at different ages. 
6.5 DQ BSA red assay 
DQ Red BSA is a fluorogenic substrate for proteases and is used as a readout of lysosomal 
function. Upon hydrolysis DQ Red BSA releases fluorescent fragments that have excitation 
and maxima emission of ~590 nm and ~620 nm. Third instar larvae were dissected to expose 
the internal organs and placed in an eppendorf tube containing 20µg/µl of DQ Red BSA 
diluted in M3 medium. The samples were incubated for different time (min 0 hour to 5 hours) 
at RT, then were fixed with 4% PFA, washed 3 times for 5 minutes with PBS 1X and then 
only wing discs were mounted on a glass slide with Mowiol. For the negative control, 
bafilomycin A1 500nM was added in samples together with the DQ Red Bsa, to inhibit 
lysosomal degradation. The samples were then analysed under a confocal microscope. 
 
6.6 RNA extraction and qPCR analysis 
RNA was obtained from fly tissues using the RNeasy kit (QIAGEN). cDNA was synthesized 
using SuoerScript VILO (Life Science Technologies) and qPCR primers were designed using 
the Universal Probe Library (UPL) Roche.  
 
6.7 Cell culture 
MCF10A cells were cultured in DMEM/F12 (1:1) supplemented with 5% Horse Serum 
(Invitrogen), 10 μg/ml Insulin, 0.5 μg/ml Hydrocortisone, 100 ng/ml cholera toxin (SIGMA) 
and freshly added 20 ng/ml EGF. All cells were cultured at 37 °C and 5% CO2 in a 
humidified incubator. To knock down genes, siRNAs against desired genes were transfected 
into MCF10A cells using the lipofectamine RNAiMax transfection reagent (Life 
technologies) by following the manufacturer's instructions.  
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6.8 Protein extraction and Western blotting 
The samples were homogenised on ice in a 1,5 µl sterile eppendorf tube containing the LBPI 
buffer (RIPA lysis Buffer + proteinase inhibitor 1:100) with autoclaved dispensable pestles. 
Depending on the tissues, 60µl of LBPI for each fly or 35µl for 10-15 heads was added. The 
tubes were left on ice for 30 minutes, and the homogenate was centrifuged at 13200 rpm for 
20 minutes at 4°C. The supernatant was finally transferred into a new tube and stored at -
20°C. Western blotting was performed according to standard techniques. Antibodies used are: 
Rabbit anti-Ref2p (gifted by T Rusten) 1:1000, rabbit anti-p62, Rabbit anti-Atg8 (gifted by 
Gabor Juchaz) 1:1000, Mouse anti-Tubulin 1:10000. 
 
6.9 Immunostainings 
Imaginal discs were fixed with 4% paraformaldeyde (PFA) diluted in H2O for 20 minutes. 
Then, samples were rinsed three times with 0.1% triton PBS1x for 5 minutes. For 
permeabilization, samples were treated for 10 minutes with 1% triton PBS1x and then the 
blocking solution, composed of 5% BSA in 0.1% triton PBS1x, was added for 30 minutes. 
Samples were incubated with primary antibodies diluted in blocking solution overnight 
(O.N.) at 4°C. Three washes in 0.1% triton PBS1x of 5 minutes each were performed. 
Secondary antibodies, diluted in PBS1x, were added for two hours at room temperature (RT). 
Samples were then rinsed three times for 5 minutes with 0.1% triton PBS1x. Eventually, 
DAPI was added for 10 minutes and then washed once with PBS1x. Samples were then 
mounted with Glycerol or Moviol (Calbiochem). The antibody used was mouse anti-NICD 
(DSHB C17.9C6) at dilution 1:100. Images were obtained with TCS microscope (Leica, 
Heidelberg, Germany) using 20x/NA 0.5, 40x/NA 1.25 or 63x/NA 1.4 oil immersion lenses. 
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6.10 Bioinformatic and data analysis 
Protein interactome data were obtained from the GeneMania database which integrates 
protein-protein interaction data from other sources (Mostafavi et al., 2008). Interactions are 
visualized in Cytoscape (Shannon et al., 2003) and Gene Ontology enrichment analysis were 
performed using the DAVID suite. Homology alignments were made using the MEGA suite 
(Kumar et al., 2016) after obtaining FASTA sequences from the NCBI database. Graphs were 
made and data were statistically analysed using either R statistical software or GraphPad 
Prism. 
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7 RESULTS 
7.1 Screening for Vps25 modifiers 
7.1.1 Knockdown of Vps25 induces a small deformed wing phenotype in adult flies 
To identify genes that modulate ESCRT activity in the wing disc, we utilised a hypomorphic 
knockdown of Vp25 by RNAi under the MS1096GAL4 driver, which directs expression in the 
dorsal wing disc compartment. A line expressing this dsRNA was generated by recombining 
the driver and a UAS Vps25 RNAi both mapping to the X-chromosome. Differently from 
generation of Vps25 null tissue in imaginal discs (Vaccari and Bilder, 2005), expression of 
the Vps25 RNAi line under MS1096GAL4, does not result in early pupal lethality indicating 
that depletion of Vps25 results in a hypomorphic phenotype.  In contrast, reduction of Vps25 
expression leads to formation of small wings that are slightly bent upwards. Such phenotype 
is specific because: (1) two independently-generated MS1096, Vps25RNAi lines produced 
similar phenotypes; (2) further reduction of Vps25 gene dosage by heterozygosity for the null 
Vps25A3 allele in the MS1096, Vps25RNAi background enhanced the phenotype leading to a 
further reduction in wing size; (3) expression of a UAS-Vps25 in the MS1096, Vps25RNAi 
background suppressed completely the phenotype leading to formation of wild-type wings; 
(4) reducing the gene dosage of AGO-2, a positive regulator of RNA interference suppressed 
the small wing phenotype (Figure 5A). The identification of a Vps25 hypomorphic 
phenotype, which is so far unreported, allowed us to establish a sensitive background to 
screen for modifiers that genetically interact with Vps25 (Figure 5A, B).  
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Figure 5: Vps25 knockdown causes a small wing phenotype sensitive to gene dosage. (A) 
The small wing phenotype is caused by specific reduction of Vps25 levels via RNAi. (B) 
Scheme showing the crossing strategy used for the screening. (C) Mutant alleles of 
trafficking genes modify the Vps25RNAi phenotype. (D) Vps25RNAi phenotype is sensitive to 
gene dosage of signalling pathway components. 
 
7.1.2 Phenotypic modification by trafficking and signalling genes 
Generation of Vps25 null mutant tissue in Drosophila imaginal discs has been shown to cause 
defects in tissue proliferation and polarity, primarily because of defective endosomal sorting 
and aberrant signalling, the latter being a consequence of the former. We therefore reasoned 
that halving the gene dosage of genes that encode components of endosomal sorting and 
signalling pathways should modify the Vps25RNAi phenotype, if these processes also 
contribute to our phenotype. To test whether the Vps25RNAi phenotype is caused by defects 
in endosomal sorting and trafficking, we crossed Vps25RNAi to mutants for ESCRT (Hrs, 
STAM, ept or tsg101, vps32, vps2, vps28) or other trafficking genes (the clathrin genes Chc 
and Clc, the syntaxins Syx7 and Syx13, the Rab family genes Rab5, Rab8, Rab28). In both 
cases, we observed modification of the Vps25RNAi phenotype (Figure 5C). Studies have 
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shown that the defects associated with ESCRT mutations is partly due to aberrant activation 
of signalling from receptors localised in the endosomes, and that fail to be degraded in the 
lysosome (Moberg et al., 2005b; Thompson et al., 2005; Vaccari and Bilder, 2005). This 
might explain why mutants for genes like Rab5, avl that regulate earlier endocytic steps, 
specifically the formation of early endosomes, suppress the Vps25RNAi phenotype, possibly 
by preventing the arrival of receptors in compartments where they can be ectopically 
activated. The situation is, however, not clear with ESCRT mutants. Indeed, we found that 
some ESCRT genes act as suppressors and others as enhancers, possibly underlining the 
complexity and diversity of ESCRT activity.  
In vps25 mutants Notch is ectopically activated in a ligand-independent and 
γ-secretase- dependent fashion (Herz et al., 2006; Vaccari and Bilder, 2005). This suggests 
that part of the phenotype of Vps25RNAi might be due to increased Notch signalling activity 
and that reduction of gene dosage of Notch signalling components might modify the wing 
phenotype. As expected, crossing to a Notch null allele suppressed the phenotype strongly. In 
fact, null alleles of positively-acting Notch signalling pathway all suppress the phenotype, 
confirming the ectopic Notch activation observed in the Vps25 null mutants. 
Upd and Dome, the JAK kinase hopscotch (hop) and the transcriptional activator STAT92E 
are essential components of the JAK/STAT signalling pathway in Drosophila. Ligand-
binding causes receptor dimerization, activating the associated JAK. JAK-mediated 
phosphorylation of the cytoplasmic receptor-tail provides binding of cytoplasmic Stat92E. 
Phosphorylation of bound STAT by JAK results in release and translocation of a STAT-
homodimer into the nucleus where it functions to transcribe target genes (Luo and Dearolf, 
2001). Vps25 null tissues in the eye disc display overactivation of JAK/STAT signalling due 
to Notch-induced overexpression of Upd (Moberg et al., 2005b; Vaccari and Bilder, 2005). 
Crossing the Vps25RNAi line with mutant alleles for JAK/STAT pathway components leads 
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to suppression of the small wing phenotype; this suggests that similarly to Vps25 mutants, 
reduction of Vps25 leads to overactivation of JAK/STAT signalling. The TGF-β/Dpp 
pathway is ectopically activated in imaginal discs that lack ESCRT activity (Thompson et al., 
2005). The fact that reducing the gene dosage of Sara and thickveins (tkv), both positive 
components of the pathway, leads to suppression of the small wing phenotype suggests that 
overactivation of the TGF-β signalling pathway contributes towards the Vps25RNAi 
phenotype. On the other hand, we unexpectedly observed that components of the 
RAS/RAF/MAPK and Wnt/Wg pathways enhance the Vps25RNAi phenotype (Figure 5D). 
This contrasts with results showing Ras and Wg activation in Vps25 mutant tissues 
(Thompson et al., 2005; Vaccari and Bilder, 2005)  
Modification by trafficking components suggest that the use of the Vps25 sensitized 
backgrounds will allow to isolate known and new trafficking genes connected with ESCRTs. 
Moreover, suppression by Notch pathway components indicates that as in the null Vps25 null 
mutant tissue, Notch is ectopically activated Vps25RNAi wings. Finally, the fact that the 
Vps25RNAi wings are reduced in size, despite activation of proliferative Notch and 
JAK/STAT signalling, strongly suggest that, as in Vps25 null mutant tissue, apoptosis is 
active in Vps25RNAi wings. 
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Figure 6: Breakdown of screening strategy. (A) We ued a deficiency screening approach to 
isolate modifiers, starting with larger defieicies, to smaller deficiencies to individual loci. The 
image shows a section of chromsome 3R. (B) Workflow of the screening approach. (C) 
Breakdown of the positive hits identified at each pass of the screening. 
 
 
7.1.3 F1 dominant modifier screen to isolate interacting loci 
To identify novel interactors of Vps25RNAi, we first conducted a systematic screen to isolate 
modifying regions on the 2nd and 3rd chromosomes. Following the strategy already described, we 
crossed Vps25RNAi with a in house-customized Bloomington deficiency kit, which is a collection 
of molecularly mapped large deficiencies arranged to maximize coverage with smallest possible 
number of stocks. When modifications were observed we used a set of smaller deficiencies 
covering the larger ones (Figure 6A-C). This proved useful to quickly identify chromosomal 
regions containing modifier loci. 
The deficiency kit that we have used is composed of 219 lines for chromosome 2 and 260 lines 
for chromosome 3; in each case, we estimated to remove > 85% of the chromosome. Altogether, 
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we identified 154 smaller regions that modify the Vps25RNAi phenotype. We identified loci that 
map to these regions and tested for modification using P-element insertions, RNAi lines and 
mutants for genes mapping to these loci. UAS-based lines (RNAi and EP insertion lines) were 
crossed to MS1096GAL4 alone as control to determine whether the wing size modification 
occurred independently of Vps25 knockdown, and genes that did were excluded. We have 
compiled a list of 204 genes that genetically modify the Vps25RNAi phenotype (Table S1).  
 
7.1.4 Computational network demonstrates wide range of functional categories 
We screened a large collection of genes, however, our screen was not saturating because: (1)  
non-modifying deficiencies could contain enhancers and suppressors erasing each other effects; 
(2) our screen was selective for haploinsufficiency effects; (3) we excluded genes that did not 
show robust modifications of the Vps25RNAi wing phenotype based on our 10% noise criteria 
and; (4) modifiers that could not be validated with at least another independent allele were 
excluded from the final list. However, based on available data in published literature, FlyBase 
and DAVID, we classified all validated modifiers into categories based on their known or 
predicted functions. As a confirmation that the screen strategy was in fact valid, membrane 
trafficking genes made up by number the largest category of previously characterised genes 
having members that included ESCRTs, syntaxins, Rabs, and intracellular trafficking proteins. 
Other classes identified include genes that encode signalling pathway components, transcription 
factors, chromatin modifiers, transporters and ion channels, cytoskeleton and motor proteins, 
metabolism regulators, and ubiquitin ligases. Interestingly, we obtained a group of 29 genes that 
have not yet been annotated and whose functions have yet to be described. Using protein-protein 
interaction data, and the GeneMania and Cytoscape tools (Mostafavi et al., 2008; Shannon et al., 
2003), we created a network diagram showing a simplified interaction map. The genes have been 
grouped and color-coded according to their functions (Figure 7A). Additionally, we performed 
Gene Ontology enrichment analysis to reveal the biological processes enriched within our gene 
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list, and we expectedly found Notch signalling and MVB sorting processes to be enriched. We 
also found other processes to be enriched significantly, possibly illustrating the biological 
relevance of ESCRTs (Figure 7B). 
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Figure 7: Analysis of Vps25 interactors.(A) Network showing the categories of genes 
identified in the primary screen. (B) Gene Ontology analysis showing biological processes 
that are enriched. 
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7.2 Secondary screening of Vps25 modifiers for growth modulators 
Previous work has demonstrated that Vps25 mutant tissues display overproliferation due to 
ectopic activation of Notch and other signalling pathways (Herz et al., 2006; Thompson et al., 
2005; Vaccari and Bilder, 2005). We therefore designed a secondary screen to identify Vps25 
modifiers that also influence tissue proliferation based on modification of a Notch-mediated 
overproliferation phenotype. To this end, we overexpressed the Notch ligand Delta under the 
control of the eyeless-GAL4 driver, which leads to eye tissue overproliferation. This background 
has already been used to screen for modifiers of growth and tumorigenesis in imaginal discs 
(Ferres-Marco et al., 2006).  The eye tissue proliferation is indeed due to activation of Notch 
signalling because: reducing the gene dosage of positive regulators in the eyGAL4, Delta 
background suppressed the overproliferation phenotype while reducing the gene dosage of 
negative regulators enhanced the phenotype (Figure 8A-G). 
 
 
Figure 8: Delta overexpression in the Drosophila eye causes overgrowth by activating 
Notch signalling. (A) wild type (B) eyGAL4-Delta, eye overgrowth induced by Delta 
overexpression. Mutant alleles of Delta (C), presenilin (D) and eyegone (E) in the eyGAL4-
Delta background suppress the eye overgrowth while a mutant allele for Nedd4 enhance the 
overgrowth (F). 
 
For the UAS-based alleles, we crossed them to eyGAL4 driver alone to eliminate those that gave 
an eye phenotype by themselves. Also, we eliminated candidates that have already been reported 
to modulate Notch signalling activity. We crossed the remaining modifiers to eyGAL4-Delta and 
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scored the F1 progeny for either enhancement or suppression of the eye phenotype. Altogether, 
we identified 43 novel candidates that induced robust modifications of the eyGAL4-Delta 
phenotype (Table 2). 
Table 2: Plot showing only the Vps25 interactors that also modify Delta-mediated eye 
overgrowth (not to scale) 
 eyGAL-Delta Suppressors eyGAL-Delta Enhancers 
Vps25RNAi  Suppressors • CG17364 
• CG17360 
• lqf 
• hh 
• eyg 
• pum 
• Taf4 
• Aos1 
• sec63 
• CG11253 
• Pinta 
• RhoGAP71E 
• CG12163 
• toe 
• slif 
• CG32109 
• CG6498/dop 
• cnc 
• l(3)76BDr 
• Hsc70-1 
• Pep 
• Nedd4 
• hyx 
• CG10147 
• Trc 
• Byn 
• CG32113 
Vps25RNAi Enhancers • CG3764 
• disp 
• sds22 
• CG31100 
• bnl 
• ImpL2 
• vhaM9.7-c 
• Arfip 
• vhaM8.9 
• bin 
• CG7369 
• Sup12-46 
• Rcd5 
• aur 
• Abl 
• ran-like 
 
 
7.3 Genetic analysis of CG6498 (dop) in eye proliferation 
One of the genes that we identified as a genetic interactor of Vps25 and modifier of eyGAL-Delta 
overproliferation phenotype is CG6498/dropout (dop), which at the time was not yet 
characterised. In fact, dop was one of the strongest enhancers of the eyGAL4-Delta eye 
overgrowth, a modification we validated using two independent lines, dopJF02778 and dopGL00220, 
referred to hereafter as dopRNAi-1 and dopRNAi-2 respectively. Because the dop lines were UAS-
RNAi lines, we checked if dop knockdown by itself altered eye phenotype by crossing the 
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dopRNAi-1 and dopRNAi-2 with eyGAL4 and found that dop knockdown had no effect on eye 
phenotype. By qPCR analysis, dopRNAi-1 and dopRNAi-2 reduced dop mRNA expression to 
29±0.04% and 75±0.05% respectively. Importantly, the strength of the knockdown (or magnitude 
of dop mRNA reduction) correlates with the severity of eyGAL4-Delta phenotype modification 
(Figure 8). Taken together, the enhancement of the eye overgrowth is due to reduction of dop 
levels in the eyGAL4-Delta background.  
 
 
 
Figure 8: Reduction of dop enhances Delta-mediated eye overgrowth by upregulating Delta 
expression. Knockdown of dop in the Drosophila eye using two RNAi lines (B, C) has no 
effect compared to wild type eye (A). However, dop knockdown in the eyGAL4, Delta 
background enhances the eye overgrowth (E, F) compared to eyGAL4, Delta alone (D). 
 
There are two possibilities as to how reduced dop levels influence growth in the eyGAL4-Delta 
background: (1) direct effect on the Notch pathway by potentiating Notch signalling or (2) 
indirect effect on growth by acting on downstream effects of ectopic Notch signalling. Notch 
activation leads to activation of the E(spl) family of transcription factors, and this is true also of 
the Drosophila eye disc. Hence, we tested if reduced dop levels altered the expression of the 
E(spl)mβ and in fact, there is a doubling in the transcription of E(spl)mβ. Importantly, the 
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magnitude of E(spl)mβ negatively correlates with the levels of dop mRNA (r2 = -0.989, using the 
R cor function). This increase in E(spl)mβ suggests the effect on growth might partly be due to a 
direct effect on activation of the Notch pathway. A direct effect on Notch pathway can be caused 
by (1) increase in Notch expression; (2) increase in the amount of ligand; (3) increase in the 
cleavage of the Notch receptor; or (4) non-canonical activation of E(spl)mβ independently of 
Notch signalling. We have checked for changes in the transcript levels of Notch and Delta: 
reduced dop levels in the eyGAL4-Delta background does not alter Notch expression but 
significantly increased the expression of its ligand, Delta (Figure 8A-G). We already know that 
the eyGAL4-Delta system is sensitive to levels of Delta; therefore, the upregulation of Delta 
might be responsible for the enhanced growth of eyGAL4-Delta eye tissue by dop 
downregulation. 
Drosophila dop protein is composed of three conserved domains: AGC kinase, PDZ 
(PSD95, Dlg, ZO-1) and DUF1908 (domain of unknown function 1908). To test which of the dop 
domains is important for its role in growth regulation, mutants of dop (Figure 9). These lines have 
already been generated by (Hain et al., 2014). Most dop mutants reproduced the effect of the dop 
RNAi lines, with dop1, a missense mutant in the kinase domain, giving the mildest effect (Figure 
10A-F). Overall, these experiments indicated that dop can control eye disc growth by acting on 
Dl levels. 
 
 
Figure 9: Location of dop mutations (Hain et al., 2014) 
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Figure 10: Mutant dop alleles enhance Delta-mediated eye overgrowth. Mutant dop 
alleles enhance Delta-mediated eye overgrowth. (A) eyGAL4, Delta (B) eyGAL4, Delta/+; 
dop1/+ (C) eyGAL4, Delta/+; dop7/+ (D) eyGAL4, Delta/+; dop9/+ (E) eyGAL4, Delta/+; 
dop10/+ 
 
7.4 Dop is the Drosophila homologue of mammalian MAST kinases 
To identify the mammalian homologues of dop, we used the NCBI BLASTp tool, which revealed 
that it is the homologue of the mammalian microtubule-associated serine/threonine-kinases 
(MAST) MAST-1, -2, -3 and -4. FASTA files of multiple alignments of downloaded protein 
sequences were created with the MUSCLE software which is part of the MEGA7.0 suite (Edgar, 
2004a, 2004b; Kumar et al., 2016) to identify the conserved domains. By specifically aligning the 
three dop domains with those of human MAST kinase paralogues, it is evident that the between 
Drosophila and humans, the kinase (KIN) domain is the most conserved while the DUF1908 
(DUF) domain is the least conserved domain (Figure 11). 
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Figure 11: Homology alignment of dop to mammalian MAST kinases 1-4 across the three 
domains 
 
7.5 Analysis of mammalian MAST2 in human epithelial MCF10A cells 
To characterise the mammalian MAST kinase family, expression levels of the individual MAST 
kinase members were assessed by qPCR across various mammalian cell lines and MAST2 was 
found to be the most expressed while MAST1and MAST4 are the least expressed (Figure 12A). 
MCF10A, a cell line derived from the breast epithelium was selected for further analysis because 
they endogenously express Notch receptors and ligands. 
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To understand if the role of MAST kinase genes in Notch signalling conserved in 
mammals, MAST2 expression was downregulated in MCF10A cells using siRNA and the effect 
on downstream Notch signalling was assessed by Hes1 expression levels. Transfection of 10nM 
siRNA against MAST2 reduced MAST2 expression by 60 percent, however, we did not observe 
any change in the expression of Notch downstream targets (HES1, HEY1), or ligands (DLL1, 
JAG1) or Notch receptors themselves (NOTCH1, NOTCH2, NOTCH3) (Figure 12B). There are 
4 MAST paralogues in mammals and the absence of an effect on the Notch pathway may be due 
to redundancy among the MAST paralogues. This is unlikely because of the following reasons: 
(1) In MCF10A, MAST2 is the most expressed of the MAST family members; (2) In other 
studies where MAST2 function was reduced either by RNAi or by using dominant negative 
constructs, no redundancy was observed (Ren et al., 2013; Xiong et al., 2004). Together, these 
results suggest that MAST2 likely has no effect on Notch signalling in human epithelial cells. 
However, we cannot rule out the role of the other MAST kinases in Notch signalling, or 
differences that exist between cell types/lines. 
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Figure 12: Analysis of MAST expression across cell lines, and effect of knockdown in 
MCF10A cells (A)Expression profiling of MAST2 expression across human cell lines reveal 
that MAST2 is the most expressed family of the MAST kinases. (B) MAST2 knockdown in 
MCF10A does not alter the expression of Notch ligands, receptors, or targets. (C) MAST2 
knockdown in MCF10A cells causes significant upregulation of MMP1, MMP9 and mild 
increase in FN1 expression. 
 
The enhancement of Drosophila eye overproliferation by dop knockdown suggests that it may 
play an anti-proliferative role. However, a study of human cancer cell lines carrying MAST1 and 
MAST2 mutations suggests that they play an growth-promoting or pro-tumorigenic role (Clay et 
al., 2013; Robinson et al., 2011). To test whether MAST2 might play a tumorigenic role 
independent of Notch signalling, we selected a panel of genes that have been shown to be 
transcriptionally altered during tumorigenesis and we analysed their expression levels upon 
MAST2 knockdown in MCF10A cells. These genes were mostly chosen from an in-house qPCR 
reaction panel and they include: CDH1 (E-cadherin), whose expression is frequently 
downregulated in breast cancer and other cancers, and is one of the main events responsible for 
dysfunctional cell-cell adhesion, invasiveness, and metastasis [reviewed in (Berx and Van Roy, 
2001)]; EGFR (epidermal growth factor receptor), whose increased expression positively 
correlates with tumour growth and aggressiveness in some cancers (Rimawi et al., 2010); FN1 
(fibronectin 1), which is upregulated transcriptionally during metastasis of colorectal, renal, 
ovarian (Chaves et al., 2012; Sudo et al., 2013; Waalkes et al., 2010); MMP (matrix 
metalloproteases)-1, -2, -7, -9, which are often overexpressed in cancers and often correlates with 
disease progression, invasiveness and metastasis (Basu et al., 2015; Cheng et al., 2008; Decock et 
al., 2007; Kohrmann et al., 2009; Kousidou et al., 2004; Luo et al., 2005; Wu et al., 2014)  (5) 
MYC, frequently mutated and found to be overexpressed in many cancers (Bièche et al., 1999; 
Sato et al., 1994); CCND2, usually hyper methylated and expressed to a lesser extent in tumours  
Other genes we tested include PTCH, CCND2, CDC25A, CDKN1A , VIM and P53 (Evron et al., 
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2001; Fischer et al., 2002; Rodriguez-Magadán et al., 2008; Sudo et al., 2013). No changes in the 
expression of these genes was observed by qPCR except MMP1 and MMP9. There also seemed 
to be an increase in FN1 expression, although this change did not reach the statistical significance 
threshold (Figure 12C). These data suggest that in contrast to Drosophila, human MAST2 might 
modulate aspects of tumorigenesis related to cell invasion. 
 
7.6 Large scale CRISPR/Cas9 mutagenesis of uncharacterised modifiers 
7.6.1 Selection of the modifiers to mutate 
29 of the modifying genes identified in the Vps25 primary screen have neither been previously 
studied or associated with any molecular process or function, and 14 of these also modified the 
eyGAL4-Dl eye overgrowth phenotype. Therefore, we selected six genes that scored positive in 
the primary and secondary screen for CRISPR/Cas9-directed mutagenesis based on a mix of the 
following criteria: (1) strength of the modification, determined quantitatively and/or visually; (2) 
presence of mammalian homologues, obtained by BLAST sequence alignment; (3) association of 
the human homologues with any disease phenotype, based on information from the DISGENET 
and OMIM databases and; (4) absence of mutant lines in the FlyBase database.  
The six selected genes are briefly described below: (1) CG10147, whose mutation suppressed 
Vps25RNAi phenotype and strongly enhanced the eyGAL4-Dl eye overgrowth. In fact, CG10147 
displayed one of the strongest eye overgrowths in the eyG4-Dl background.  CG10147, based on 
domain homology, encodes a zinc finger containing protein. In this case though, CG10147 does 
not have a clear human orthologue; however, it was selected because of the very strong growth 
modification and because we validated the modification using 3 independent RNAi lines;                     
(2) CG11876 ― a suppressor of both Vps25RNAi and eyGAL4-Dl phenotypes ― encodes a 
protein that appears to be a central hub connecting several trafficking proteins using available 
protein-protein interaction data. Homology alignment with the mammalian orthologues suggests 
that CG11876 codes for pyruvate dehydrogenase, a mitochondrial enzyme, whose mutations 
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cause an autosomal recessive disease called pyruvate dehydrogenase E1-beta deficiency 
(Okajima et al., 2008). Whether defects in endosomal trafficking contributes towards this 
pathology is presently unclear. (3) CG12163, encodes a protein that shares strong homology with 
mammalian Cathepsin F (CTSF). Cathepsins mostly function in the lysosomes to hydrolyse and 
digest lysosomal contents. CTSF mutations have been shown to cause a type of neuropathology 
referred to as adult-onset neuronal ceroid lipofuscinosis (or Type B Kufs disease) (Smith et al., 
2013; Tang et al., 2006a). Also, it is a suppressor of both Vps25RNAi and eyGAL4-Dl 
phenotypes. (4) CG3764, encodes the Drosophila homologue of mammalian folliculin-interacting 
proteins 1 and 2 (FNIP1/2); FNIP1 and FNIP2 are two of the seven proteins that have been 
demonstrated to interact with folliculin (FLCN), and they are both essential for folliculin function 
(Hasumi et al., 2015; Takagi et al., 2008). Mutations in folliculin have been shown to be 
responsible for the Birt-Hogg Dube syndrome, a rare disease characterised by small benign skin 
lesions (folliculomas), lung cysts and kidney cancer (Chen et al., 2008; Hudon et al., 2010). 
FLCN, by being a part of the Tor/TSc pathway plays important  roles in cell/tissue growth, 
autophagy, and organismal lifespan (Gaur et al., 2013; Hasumi et al., 2008; Piao et al., 2009). (5) 
Mkrn1, orthologue of mammalian Markorin E3 ubiquitin ligase, have not been characterised 
sufficiently in Drosophila but have been demonstrated to regulate telomerase activity, p53 
stability and gene transcription in mammalian systems (Kim et al., 2005; Lee et al., 2009a; 
Omwancha et al., 2006; Salvatico et al., 2010). (6) CG32113, homologue of mammalian 
Vps13D belongs to the Vps13 family of genes that in yeast have been described to function in 
Golgi to pre-vacuole trafficking (Bryant and Stevens, 1998; Stack and Emr, 1993). 
 
7.6.2 Generation of knock-out mutants 
For the design of guide RNAs we used the MIT CRISPR design tool (http://crispr.mit.edu/, 
Zhang Lab, MIT). We targeted gene regions that code for predicted functionally important 
domains, because it has been demonstrated that this approach yields stronger phenotypes 
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compared to the targeting of regions outside these domains (Shi et al., 2015). For CG10147, 
we selected exon 2, which codes for the zinc finger domain; for CG12163, exon 4 which 
codes for the first part of the peptidase domain; for CG3764, exon 5, expected to encode the 
region predicted to bind folliculin based on mammalian structural analysis; for CG11876, 
exon 2, predicted to code for a part of the transketolase domain. 
Briefly, we cloned the gRNA into pBFv-U6.2 vectors, integrated them into the fly genome at 
chromosome 2. Transgenic male flies carrying the gRNA and female flies carrying the nos-
Cas9 (nos is a germline specific driver) were crossed to together and the resulting progeny 
was analysed for presence or absence of mutations (Kondo and Ueda, 2013) [Details are 
described in the Materials and Methods section]. We isolate the intended mutations, we used 
3 approaches: (1) T7 E1 endonuclease assay to identify large insertions or deletions (indels) 
that cause heteroduplexes after annealing DNA strands; (2) DNA sequencing to ascertain the 
mutation type and status and; (3) Genetic complementation tests, useful only in cases where 
the mutation causes lethality when homozygous. 
We started out initially using the T7 endonuclease assay to screen potential mutants and 
identified potential indels in 22 of 43 stocks for CG12163, 5 of 44 stocks for CG10147, 23 of 
28 stocks for Mkrn1, 19 of 40 stocks for CG3764 (Figure 13). DNA sequencing on amplified 
regions flanking the Cas9 cleavage site was performed on selected mutants for confirmation. 
Since the flies at this stage were heterozygous, having mutant and wild type chromosomes, 
we observed the presence of double peaks beginning at the Cas9 cleavage position. We also 
sequenced a sample of other stocks that did not score positive for the T7 E1 assay, that is, 
those with single bands, and found that some of them were indeed mutants having single base 
deletion/insertion, resulting in a frameshift, and predicted to yield a truncated protein. This 
indicates that, in our hands, the T7 E1 assay might not be sensitive enough to detect small 
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indels. Thus, for further screening of mutants, we ignored the T7 E1 assay and focused on 
DNA sequencing.  
Except for Mkrn1 and CG3764, homozygous mutants of the other genes were viable. For the 
homozygous mutants, DNA sequencing was reperformed and the region surrounding the 
Cas9 cleavage site was aligned with the corresponding wild type region to validate the 
mutation. Mutant alleles for Mkrn1 and CG3764 failed the complementation test when 
crossed to their corresponding deficiency lines, confirming that their mutations were indeed 
homozygous lethal. Mutant lines for all genes were established and stocked. 
 
Figure 13: T7 endonuclease assay to identify indel mutants generated by CRISPR/Cas9. 
Presence of triple bands per lane suggests the presence of indels greater than 3 bases. 
 
7.7 Preliminary characterisation of CG12163 mutants 
7.7.1 CG12163 mutations cause reduction in CG12163 gene expression and potentially 
lead to loss of the peptidase domain 
We focused on CG12163 for further characterisation because: (1) being a cathepsin F 
orthologue, it most likely functions in the lysosome and may directly or indirectly influence 
58 
 
downstream endocytic trafficking outcomes including signalling (Sorkin and von Zastrow, 
2009; Turk et al., 2012); (2) the human orthologue cathepsin F causes an adult-onset form of 
neuronal ceroid lipofuscinosis (NCL), called Type B Kufs disease, whose mechanisms are 
presently unclear (Di Fabio et al., 2014, 2015; Smith et al., 2013). We observed that 
CG12163 is expressed predominantly in the fly head compared to the rest of the other tissues, 
in agreement with available expression data from FlyBase, also suggesting that its role in 
neuronal health may be conserved in Drosophila. 
 
 
Figure 14: Description of CG12163 mutants. (A) CG12163 is predominantly expressed in 
the adult fly head compared to the rest of the body. (B) Most of the mutations cause reduction 
in CG12163 transcript levels possibly due to mRNA decay. (C) CG1216317, CG1216318, 
CG1216325 mutations are predicted to encode a truncated protein lacking the functional 
peptidase domain. 
 
All the CTSF mutations associated with this form of NCL occur in the peptidase domain 
except one and in vitro biochemical analyses have shown that the enzyme resulting from all 
these mutants lead to reduced peptidase activity (Smith et al., 2013) (Peters et al., 2015). 
Because these evidences suggest that that the disease results from loss of peptidase activity, 
our CG12163 CRISPR/Cas9 mutants targeting the peptidase domain might represent models 
of the disease in flies. Based on DNA sequencing of the mutants, we selected those predicted 
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to lack the peptidase domain. We test if these mutations affect mRNA transcript levels by 
qPCR analysis because the exon position of premature termination codons have been shown 
to affect mRNA decay (You et al., 2007). CG1216317, CG1216318 and CG1216325 were 
selected for further analysis because they reduce the mRNA levels of CG12163 by 89%, 81% 
and 85% respectively. Also, the residual mRNA for these mutants are predicted to a produce 
truncated protein lacking the peptidase domain (Figure 14). 
7.7.2 CG12163 mutation as a fly model of Type B Kufs disease 
Since human patients with CTSF mutations and mice lacking Cathepsin F display 
neurological phenotypes in mid-life and premature death (Smith et al., 2013; Tang et al., 
2006a), the lifespan of CG12163 mutant flies was assessed. Among the three mutants, only 
CG1216317 flies surprisingly displayed reduced survival while other mutants had similar 
lifespan as control flies (Figure 15A). 
. 
  
Figure 15: Phenotypic characterisation of CG12163 mutants. (A) Only one of the mutants 
showed reduced survival compared to controls. (B) Young 1-day old mutant flies did not 
display any difference in survival under oxidative stress conditions in 3% H2O2. (C) Old 25-
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day old mutant flies are sensitive to oxidative stress, except CG1216318. (D) All mutants 
displayed an age-dependent decline in motor ability measured by negative geotaxis. 
 
Since oxidative stress has been shown to influence models of neurodegeneration in flies, we 
asked if CG12163 has any role in resistance to oxidative stress. Briefly, we examined the 
survival of CG12163 mutant flies after acute exposure to the potent oxidizer hydrogen 
peroxide (H2O2). Young 1-day old grown on media supplemented with H2O2 at a final 
concentration of 3% did not show marked differences in survival compared to control flies as 
observed from the slope of the curves (Figure 15B). However, old mutant flies (25-day old) 
except CG1216318  showed increased sensitivity to oxidative stress (Figure 15C). This 
suggests that: (1) at least to an extent, CG12163 influences hypersensitivity to oxidative 
stress and; (2) the consequence of CG12163 mutations take effect in later stages of the fly 
life, consistent with late/adult-onset phenotypes observed in mammalian CTSF mutants 
(Smith et al., 2013; Tang et al., 2006a). We hope to account for the phenotypic differences 
among the 3 mutants by performing rescue experiments, and by including other mutants in 
future experiments to rule out off target effects. Notwithstanding this disparity, all three 
mutants displayed marked reduction in motor ability measured by the number of flies able to 
climb up to a specified height within a specified time (Figure 15D). In fact, the severity of the 
climbing defect increased with age. Taken together, CG12163 influences certain aspects of 
neuronal function in Drosophila. Brain vacuolisation is one of the typical signs of neuronal 
loss in Drosophila brain. In 30-day old flies, we observed slightly increased brain vacuoles 
compared to controls (Figure 16). 
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Figure 16: Adult brains of CG12163 mutants display slightly increased brain vacuoles. 
Black arrows indicate position of vacuoles. 
 
 
 
 
 
One of the pathological features of NCL is the accumulation of autofluorescent granules in 
the brain tissues of patients due to accumulation of lipofuscin (Di Fabio et al., 2015; Smith et 
al., 2013). In a Drosophila NCL model carrying Cathepsin D mutation, autofluorescence 
could also be observed in adult brains (Kuronen et al., 2009; Myllykangas et al., 2005). We 
decided to examine larval wing discs of mutant flies and were surprised to find that they 
display tissue autofluorescence so early in development (Figure 17). 
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Figure 17: CG12163 larval wing discs display autofluorescence. 
 
Since CG12163 was isolated as both a Vps25 and a Delta modifier, we wondered whether the 
mutants display any defect in Notch signalling. We probed mutant tissues with an antibody 
against the cleaved intracellular form of Notch, and did not observe any change in Notch 
activation (Figure 18). Thus, CG12163 mutation on its own does not influence Notch 
signalling in the Drosophila brain.  
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Figure 18: CG12163 mutant wing discs do not display changes in Notch cleavage, based on 
levels of Notch intracellular domain (NICD) 
 
 
Cathepsin are lysosomal proteases and are important for lysosomal functionality. We 
therefore wondered if the CG12163 mutants have defective lysosomes. Using the dqBSA 
assay which measures the ability of the lysosome to cleave a fluorogenic substrate, we 
observed no gross changes in lysosomal function (Figure 19). This suggests either CG12163 
mutations are not sufficient to induce lysosomal dysfunction or the changes in lysosomal 
function are beyond the sensitivity of our assay. 
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Figure 19: CG12163 mutant larval wing discs do not display gross defects in lysosomal 
function, measured using the dqBSA assay. 
 
 
 
7.7.3 CG12163 loss causes p62 degradation and transcriptional upregulation of Atg8 
CG12163, being the potential orthologue of CTSF, is predicted to be a lysosomal enzyme and 
studies have extensively linked the autophagy-lysosomal pathway with maintenance of 
neuronal health. Also, several lysosomal proteins have been shown to affect autophagy 
[reviewed in (Mrschtik and Ryan, 2015; Son et al., 2012)]. To check for autophagic 
dysfunction, we performed immunoblotting against p62 on brain extracts of CG12163-
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deficient flies. p62 links ubiquitinated proteins to the autophagic machinery, leading to their 
degradation (Rogov et al., 2014). When autophagy is defective, p62 accumulates and this 
have been shown to be functionally important in several types of neuropathologies (Bartlett et 
al., 2011). Western blot analysis on adult heads revealed alteration in p62 levels. Rather than 
increased p62, which is almost a hallmark of several neurological diseases, we observed 
reduced levels of p62 across the three mutants (Figure 20A). This reduced level of p62 is 
post-transcriptional because we did not observe a change in p62 transcript levels (data not 
shown). Taken together, CG12163 loss might alter autophagic processes by influencing the 
p62 stability or by accelerating p62 clearance. 
 
Figure 20: CG12163 mutant brains display alteration of autophagy. (A) p62 protein 
levels are reduced in 30-day old adult mutant heads. (B) CG12163 mutant adult heads all 
display transcriptional upregulation of Atg8, but not Lamp1. 
 
Transcription factor EB (TFEB) gene is a master regulator of lysosomal biogenesis and 
autophagy and its activity is critical for autophagic clearance by regulating expression of 
genes belonging to the Coordinated Lysosomal Expression and Regulation (CLEAR) network 
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in mammals and flies (Bouché et al., 2016; Roczniak-Ferguson et al., 2012; Settembre et al., 
2011, 2012; Tognon et al., 2016). One of the genes acting downstream of TFEB (Mitf in 
Drosophila) which is crucial for autophagosome formation and maturation is Atg8. By qPCR, 
we observed upregulation of Atg8 transcript levels in all three CG12163 deficient lines. In 
contrast, the lysosomal gene Lamp1, which is also a TFEB target is significantly upregulated 
only in one of the mutants (Figure 20B). These results indicate that loss of CG12163 induces 
an autophagic response in adult fly heads that is regulated at transcriptional level and might 
be at least partially independent of TFEB, since Lamp1 is not comparably elevated.  
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8 DISCUSSION 
Here, we report the first in vivo genetic screen for ESCRT gene Vp25 in Drosophila, which 
allows systematic dissection of interacting genes. Our results support the idea that Vps25 and 
indeed ESCRT functions influence multiple cellular pathways. Importantly, some of the 
genes that we have identified as modifiers are not characterized, but have human homologues 
that have been associated with various diseases. Our results thus have the potential to uncover 
genes that play important roles in regulating the downstream effects of ESCRT, including but 
not limited to endosomal sorting and signal transduction; and this may be relevant in diseases 
such as some forms of cancer and neurodegeneration. Some of them have been previously 
associated to ESCRTs, but most others are not yet. This is highlighted by our identification of 
dop, the Drosophila homologue of mammalian MAST kinase genes, whose mutations have 
been linked with breast and other cancers; and CG12163, the Drosophila homologue of 
mammalian cathepsin F, whose mutations cause a rare form of neuronal ceroid lipofuscinosis 
in humans. The implications of our findings are detailed below. 
 
8.1 Involvement of ESCRTs and endosomal sorting in a wide range of biological 
processes. 
Consistent with our initial expectations, our results showed that Vps25 genetically interacts 
with key endosomal and trafficking genes such as Vps22/lsn, Vps24, Vps36, Chmp1, Syx7, 
Syx13, Rab8 and sec63. However, loss of one copy of these genes did not yield the same type 
of modification. We will attempt to explain the reasons that could account for this difference, 
focusing on ESCRT genes.  
We expected that reducing the gene dosage of any ESCRT gene would enhance the 
Vps25RNAi phenotype, due to aggravation of the endosomal sorting defect. However, while 
Vps2 and Vps22/lsn acted as enhancers, Vps36 acted as a suppressor. Vps22 and Vps36 
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interact to form one lobe of the trilobar ESCRT-II complex and two Vps25 subunits make up 
the remaining complex (Hierro et al., 2004; Im and Hurley, 2008; Teo et al., 2004). Although 
Vps36 and Vps22 belong to the same complex, intrinsic structural differences between them 
might dictate specific roles they play in cargo sorting at the endosome, and the resulting 
biological outcomes. Indeed, there are examples that demonstrate that Vps36 are likely to 
possess specific functions, independent of the other two ESCRT-II subunits: (1) Although the 
observation that tissues entirely mutant for Vps22, Vps25 and Vps36 all display neoplastic 
phenotypes (with similar accumulation of ubiquitinated proteins and ectopic activation of 
Notch, JAK/STAT, JNK signalling pathways) does not support the existence of differences 
among these subunits (Herz et al., 2009; Woodfield et al., 2013a), analyses of  mutant clones 
in mosaic Drosophila imaginal discs reveal that Vps36 differs from either Vps22 or Vps25 in 
terms of hyperplastic non-autonomous overgrowth of neighbouring wild type tissues, 
apoptosis and Notch signalling (Herz et al., 2009). While Vps22 and Vps25 clones induce 
non-autonomous overgrowth and ectopic Notch signalling, Vps36 clones do not (Herz et al., 
2009; Thompson et al., 2005; Vaccari and Bilder, 2005); (2) In a study describing the role of 
ESCRT-II in localisation of the bicoid mRNA in Drosophila oocyte, vps36 but not the other 
subunits was shown to specifically bind the bicoid mRNA and regulate its localisation, thus 
playing a role likely independent of endosomal trafficking (Irion and St Johnston, 2007); (3) 
Vps36, by virtue of its GLUE domain (Hierro et al., 2004; Im and Hurley, 2008; Slagsvold et 
al., 2005; Teo et al., 2006) is able to specifically interact with specific cargoes like Smo of 
the Hedgehog signalling pathway (Yang et al., 2013). Although we have not directly tested 
these features of   the ESCRT-II complex in our system, it is plausible that these might play a 
role in the phenotypic modifications we have observed. This observations might not only 
apply to vps36 alone, as other ESCRT-II subunits can perform specific functions independent 
of endosomal sorting (Ghoujal et al., 2012). 
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Gene ontology analysis and functional classification of modifying genes revealed that 
several biological processes might influence or be influenced by Vps25 function. Generally, 
our Vps25 interaction network suggest that endosomal sorting is a prominent function, 
relative to others because most of the modifiers that we identified are directly involved with 
trafficking, and ubiquitin-dependent MVB sorting is one of the pathways most significantly 
enriched in our gene lists. Other enriched processes or functional gene classes were as 
expected; signalling [reviewed in (Constam, 2009; Gonzalez-Gaitan and González-Gaitán, 
2003; Sigismund et al., 2012)], apico-basal polarity (Lu and Bilder, 2005; Rodahl et al., 2009; 
Vaccari and Bilder, 2005, 2009); ubiquitination [reviewed in (Haglund and Dikic, 2012; 
Katzmann et al., 2001; Polo, 2012; Raiborg and Stenmark, 2009; Shields and Piper, 2011)]. 
Here, we will attempt, using the literature and synthesis, to focus on novel and unexpected 
interactions for which the link with ESCRTs is not immediately apparent. 
8.1.1 Modification by cell division, DNA replication and repair genes 
We have identified genes encoding regulators of cell division and DNA replication as 
modifiers of the Vps25RNAi phenotype. Some of these genes, such as Bub1, Mad1 and AurA 
function at the spindle assembly checkpoint (Chen, 2002; Emre et al., 2011; Krenn and 
Musacchio, 2015; Logarinho et al., 2004); Rcd5, functions in duplication of the centriole and 
also in transcription (Dobbelaere et al., 2008; Raja et al., 2010); Chro, maintains microtubule 
spindle dynamics and chromosome structure (Ding et al., 2009; Rath et al., 2004, 2006); mgr, 
maintains the structure of spindle poles (Delgehyr et al., 2012; Gonzalez et al., 1998; 
González et al., 1988); ens, regulates microtubule growth and centrosome separation (Barlan 
et al., 2013; Gallaud et al., 2014; Sung et al., 2008); gwl, controls proper chromosome 
segregation (Archambault et al., 2007; Wang et al., 2013; Yu et al., 2004); cdc25, regulates 
cell cycle progression (Edgar and O’Farrell, 1989, 1990); Rfc4, regulates cell cycle 
checkpoint and DNA replication (Krause et al., 2001); Irbp/Ku70, is involved in non-
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homologous end joining of DNA strand breaks and maintenance of telomere length in 
Drosophila (Melnikova et al., 2005; Min et al., 2004); mei-P22, is required for meiotic 
recombination during oogenesis (Liu et al., 2002a); okr, functions in the DNA repair pathway 
(Ghabrial et al., 1998).  
The fact that we identified cell division genes as modifiers is not entirely surprising, 
given the body of evidences demonstrating the role of Drosophila ESCRT complexes in 
cytokinesis; this however, has not been observed in mammalian cells. In fact, it is likely that 
ESCRTs evolved as a machinery for cytokinesis (Field and Dacks, 2009). Although ESCRT-
II have been shown to be largely dispensable for the abscission part of the cytokinesis process 
(McCullough et al., 2013), studies have revealed that ESCRT-II components Vps25 and 
Vps36 also localise to the cytokinetic bridge and are responsible for recruiting ESCRT-III 
components (Goliand et al., 2014). It is thus possible that some of the phenotypes associated 
with ESCRT-II mutants or RNAi knockdown might result cell division defects. More 
generally, endocytosis and trafficking play important roles at several stages of cell division 
(Chen et al., 2012; McKay and Burgess, 2011). For example, the Rab5 GTPase regulates 
nuclear envelope breakdown at mitotic entry and also regulates proper chromosome 
alignment (Capalbo et al., 2011; Lanzetti, 2012), Rab11 regulates spindle alignment (Ai et 
al., 2009; Zhang et al., 2008), the SNARE protein Snap29 promotes assembly of the 
kinetochore (Morelli et al., 2016), syntaxin 16 is required for the accumulation of recycling 
endosomes and recruitment of ESCRT machinery to the midbody at late telophase (Neto et 
al., 2013). Conclusions that can be drawn here are: (1) our study further confirms the function 
of endosomal sorting genes in cell division processes; (2) cell division defects might underlie 
several defects associated with depletion of ESCRT components in Drosophila tissues; (3) 
cell division aberrations might also contribute to human pathologies caused by either 
defective endosomal sorting or mutations of endocytic genes. 
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There is not much known about the function of ESCRT proteins or endosomal 
sorting/trafficking in DNA repair and genome stability. In yeast, ESCRT subunits are 
required to prevent accelerated shortening of telomeres (Dieckmann et al., 2016), and 
ESCRT-III in mammalian cells protect against DNA damage by regulating nuclear envelope 
assembly (Vietri et al., 2015). There might be more indirect ways by which ESCRTs or 
endosomal sorting events might protect against DNA damage, such as: (1) regulation of 
autophagy – ESCRTs have been shown to play important roles in autophagic events (Rusten 
and Simonsen, 2008; Rusten et al., 2007), and defective autophagy causes increased DNA 
damage and chromosomal aberrations. Also, autophagy via ubiquitin signalling regulates the 
activity of DNA repair proteins  (Feng and Klionsky, 2017; Wang et al., 2016; Xu et al., 
2017); (2) by promoting proper cell division, ESCRT and endosomal sorting might contribute 
towards maintenance of genome stability (Bakhoum et al., 2017; Ganem and Pellman, 2012; 
Heijink et al., 2013); (3) We now know that ESCRTs and endosomal sorting control multiple 
signalling pathways, and this might indirectly regulate DNA damage/repair, for example, 
JAK/STAT signalling pathway activates ATM-mediated DNA damage response (Hong and 
Laimins, 2013; Rosen et al., 2010; Silver-Morse and Li, 2013) and Notch signalling 
negatively regulates DNA damage response (Adamowicz et al., 2016; Vermezovic et al., 
2015). In addition, analysis of modifiers identifies the GO term ‘response to oxidative stress’ 
as being significantly enriched. It is still unclear the precise role of ESCRT in DNA damage 
response and this merits further investigation. Perhaps, genome instability contributes to 
some of the human pathologies like cancer and neurodegeneration that are caused by ESCRT 
mutations. 
8.1.2 Modification by RNA processing genes 
Since our screen is based on modification of an RNAi phenotype, we initially thought 
modifiers involved with RNA processing might reflect non-specific modification of the 
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Vps25RNAi phenotype rather than genetic interaction. Although we cannot completely rule 
this out, studies have demonstrated that ESCRT proteins directly regulate RNA processing. 
As previously discussed, one of the early evidences show that Vps36 determines correct 
localisation of bicoid mRNA in the Drosophila oocyte and this is dependent on the RNA-
binding protein Staufen (Irion and St Johnston, 2007). Further studies have shown that 
ESCRTs control microRNA (miRNA) activity by associating with components RNA-induced 
silencing complex (RISC) (Gibbings et al., 2009), and ESCRT-II proteins bind Staufen and 
the HIV-1 Gag protein, and this interaction is responsible for the genomic trafficking of HIV-
1 viral RNA (Ghoujal et al., 2012). The contribution of ESCRTs on RNA metabolism in 
physiological or pathological conditions is unknown but it might include direct effects on 
gene expression. Indeed, prior to the discovery of their role in regulation of membrane 
events, mammalian ESCRT-II proteins were reported to form a complex with the RNA 
polymerase II elongation factor ELL in order to exert transcriptional control activity (Kamura 
et al., 2001; Schmidt et al., 1999). 
 
8.2 A strategy to identify novel regulators of cell growth associated to Notch and 
endosomes 
We used a Delta-induced eye overgrowth system as a secondary screen to identify those 
Vps25 modifiers that also influence tissue growth. The rationale was to uncover those 
modifiers that might be relevant for the role of Vps25 in tumorigenesis, and we isolated 43 
genes that modify both Vps25 downregulation and Delta overexpression. Overexpression of 
the Notch ligand Delta under the eye-specific promoter  (eyGAL4-Dl) causes a non-metastatic 
overproliferation and has been used to identify genes that influence tumour growth in 
Drosophila (Ferres-Marco et al., 2006; Herz et al., 2010; Miles et al., 2011). Some of our 
eyGAL4-Dl modifiers like eyg, toe, lqf are already known to be components of Notch 
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signalling pathway (Dominguez et al., 2004; Overstreet et al., 2004; Tian et al., 2004; Zhu et 
al., 2017). Others like Abl, disp, hyx, ImpL2 and bnl function in other signalling pathways, 
highlighting the emerging concept that the endosome acts as a nexus for intracellular signal 
transduction (Bader et al., 2013; Burke et al., 1999; Mosimann et al., 2006; Singh et al., 2010; 
Sutherland et al., 1996). We also have found genes that encode V-ATPase subunits, cell 
division regulators and several uncharacterised genes as modifiers of eye overgrowth. Taken 
together, the modifiers identified with the eyGAL4-Dl secondary screen either directly affect 
Delta/Notch signalling or may affect downstream pathways that are required for tissue 
growth. 
8.3 Drosophila dop might control Notch signalling by regulating Delta expression 
One of the previously characterized tissue growth modifiers is dop, the Drosophila 
homologue of mammalian MAST kinase genes. To be best of our knowledge, this is the first 
time dop has been linked with tissue growth. dop has previously been shown to regulate 
cellularisation of the Drosophila embryo during development (Galewsky and Schulz, 1992; 
Hain et al., 2014). In our hands, loss or reduced dop expression enhances the Delta-mediated 
overgrowth, suggesting that dop activity is antagonistic to the excessive growth caused by 
ectopic Notch activity. In fact, we have observed, also for the first time, that reduced dop 
levels cause an increased expression of Delta mRNA, and this also correlates with the 
increase in expression of the Notch target, E(spl)mβ. This seems to be specific because we 
did not observe a change in the expression of Notch. Since regulation of Delta expression and 
Notch signalling is important during development, it will be interesting to understand if dop 
might influence cell fate and lateral inhibition during development. Since proneural proteins 
positively regulate Delta expression (Bertrand et al., 2002), perhaps, dop might influence the 
activity of proneural factors, perhaps by phosphorylation. The exact mechanism demands 
further study. Alternatively, mammalian MAST kinases have been found to associate with, 
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and control the stability and cellular localisation of the tumour suppressor protein PTEN 
(Terrien et al., 2012; Valiente et al., 2005). Thus, it will be interesting to test in the future 
whether dop regulates growth independently of Notch signalling by acting on the PTEN/PI3K 
pathway.  
8.4 Mammalian MAST2 does not influence Notch signalling but might regulate other 
pathways 
We find that knockdown of MAST2 in MCF10A cell lines, which endogenously express 
most Notch pathway proteins, does not change the expression of Notch-related genes. We 
selected MAST2 because it is the founding member of the MAST kinase family (Walden and 
Cowan, 1993) and the most expressed in MCF10A cells. Our negative results suggest that: 
(1) the role of Drosophila dop in Notch signalling is not conserved in mammals; (2) MAST 
kinase proteins other than or in addition to MAST2 might be performing this role. We will 
need to knockdown the other MAST genes both individually and simultaneously to identify 
which of these possibilities is the case. 
In human breast cancers, translocations involving MAST1 and MAST2 have been 
identified (Robinson et al., 2011). However, little is known about the biological role of 
MAST kinases. MAST2 (also known as MAST205) was initially identified in microtubules 
of the spermatid, where it was found to play a role in sperm maturation (Walden and Cowan, 
1993; Walden and Millette, 1996). MAST2 also regulates the activity of ion channels (Ren et 
al., 2013; Wang et al., 2006). Most of these findings do not point to an obvious explanation 
of how MAST kinase activity or inactivity might cause or promote tumour development. In 
contrast, the discovery that MAST2 binding to PTEN enhances its stability, promotes 
phosphorylation and nuclear relocalisation or retention of PTEN (Terrien et al., 2012; 
Valiente et al., 2005), suggest how MAST kinases might influence cell growth during 
development. 
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We have attempted to understand how MAST2 might promote tumorigenesis by 
analysing the expression of genes whose levels are known to be important for tumour 
development. The transcripts of FN1, MMP1 and MMP9 were observed to be upregulated 
upon MAST2 knockdown in breast epithelial cells MCF10A. What these 3 genes have in 
common is that they all are transcriptional targets of the nuclear factor kappa B (NF-κB) 
signalling pathway (He, 1996; Lee et al., 2002; Norton et al., 2004; Vincenti et al., 1998). 
Briefly, the NF-κB pathway is activated by the binding of a ligand to a cell surface receptor 
(e.g., tumor necrosis factor-receptor (TNF-R) or a Toll-like receptor), which leads to 
recruitment, activation and relocalisation of several complexes. This culminates in the 
nuclear translocation of active NF-κB complexes where they induce gene expression, either 
alone or in combination with other transcription factors (Gilmore, 2006). This pathway have 
been shown to be play a key roles in immunity, inflammation, development and importantly 
in cancer (Karin, 2006). Interestingly, MAST3 has been shown to be either positively 
inversely correlated with increased NF-κB-driven inflammation during inflammatory bowel 
diseases (Labbé et al., 2008, 2012; Majumdar et al., 2017). The strongest evidence comes 
from the fact that by binding to TRAF6 (an E3 ubiquitin ligase), MAST2 might negatively 
regulate NF-κB activity (Funakoshi-Tago et al., 2009; Xiong et al., 2004). Taken together, 
MAST2 or MAST kinases in general, might influence cancer development and progression 
by regulating the NF-κB signalling pathway. Although, Robinson and colleagues have 
reported that the genetic alterations of MAST1 and MAST2 in breast cancers lead to their 
transcriptional upregulation (Robinson et al., 2011), bioinformatics analysis of cancer 
databases shows that several other cancers carry mutations in MAST kinase genes. Perhaps it 
is misregulation, rather than downregulation, of MAST kinases that promote tumour 
development. Also by regulating FN1, MMP1 and MMP9 expression, MAST kinases might 
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influence epithelial-to-mesenchymal transition, and invasiveness during tumour development 
(Foda and Zucker, 2001; Lamouille et al., 2014). 
 
8.5 Insights into human type B Kufs disease derived from the Drosophila model 
A number of Vps25 and Delta modifiers were uncharacterized genes. One of these is 
CG12163 is the putative homologue of mammalian lysosomal enzyme cathepsin F. 
Mutations in human cathepsin-F cause an adult-onset form of neuronal ceroid lipofuscinosis  
(NCL) called type B Kufs disease (Smith et al., 2013; Tang et al., 2006b; van der Zee et al., 
2016). Thus, we decided to use Drosophila to study CG12163function in vivo and possibly 
establish for the first time a fly model of type B Kufs disease. Using CRISPR/Cas9, we 
generated knock-out lines with indels in the peptidase domain, the active part of the enzyme. 
In fact, in vitro evidences indicated that the human mutations impede the peptidase activity of 
the protein (Peters et al., 2015). Although, it is not currently known if the human mutations 
affect transcript levels in our fly mutants we observed almost complete loss of CG12163 
transcript in our mutant lines, suggesting that also human mutations might be subjected to 
non-sense mediated RNA decay. NCLs are caused by accumulation of lipopigments in nerve 
cells leading to atrophy and patients with this form of NCL present difficulty coordinating 
voluntary movements (ataxia), speech difficulties, dementia and/or psychotic behaviour and 
premature death (Smith et al., 2013; Tang et al., 2006a; van der Zee et al., 2016). The fact 
that CG12163 is expressed predominantly in the fly head suggests that it may be relevant as a 
human model of the disease. Typical neurodegenerative phenotypes in Drosophila consist of 
reduced lifespan, locomotor defects, brain vacuolisation and sometimes increased sensitivity 
to oxidative stress (Sang and Jackson, 2005); a more specific NCL phenotype is the 
accumulation of lipofuscin. Although not all the three mutant lines displayed these 
phenotypes, at least 2 out of 3 mutant lines that we analysed displayed reduced locomotor 
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activity assayed by negative geotaxis, slightly increased brain vacuolisation compared to 
control, tissue autofluorescence and hypersensitivity to oxidative stress, Exactly why 
differences exist between the three mutants that we have studied is currently unclear. 
Whether this is due to off target effects of CRISPR or whether it reflects intrinsic diversity 
among the mutations will be a focus of future analysis. Indeed, it is possible that the stability 
or nature of the proteins produced from the residual mutant transcripts differ; should this be 
the case, this still does not account for why some phenotypes are common among all mutant 
lines and others are not. Despite this, our mutants recapitulate several aspects of the human 
disease suggesting that Drosophila may be a good model to understand the Type B Kufs 
pathogenesis.  
 
8.6 NCLs and autophagy 
Results of the dQ-BSA assay which measures digestive ability of the lysosome (Vázquez and 
Colombo, 2009) suggest that there is no marked change in the general ability of the lysosome 
to degrade substrates; this is reasonable because loss of one cathepsin might not be sufficient 
to observe a significant change, unless the enzyme has a broad-spectrum substrate. Thus, it 
would be interesting to assay in the future cleavage with more specific substrates. Indeed, in 
other forms of NCL due to loss of Cathepsins, the lysosomal defects can be quite specific 
(Holopainen et al., 2001; Koike et al., 2000). Because autophagy and lysosomal function are 
highly coordinated (Settembre et al., 2011) , we also assessed how autophagy functions in 
CG12163 mutants. Autophagy has not been studied in the context of Type B Kufs disease but 
it might be very important for pathogenesis. 
Indeed, increase in protein levels of the autophagy adapter p62, due to impaired 
autophagy is often found in aging brain and is observed in Drosophila models of 
neurodegeneration, as well as in autophagy gene mutants (Hara et al., 2006; Komatsu et al., 
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2006). Consistent with the possibility that type B Kufs disease involve alteration of 
autophagy, we found changes in p62 expression in CG12163 mutants. Rather than increase, 
we found reduction compared to control, suggesting that autophagy is somehow accelerated 
in CG12163 mutants. Two of the conditions that promotes autophagy and p62 reduction are 
oxidative stress and hypoxia (Pursiheimo et al., 2009; Small et al., 2014). CG12163 mutants 
are likely under oxidative stress, as evidenced by their hypersensitivity to hydrogen peroxide. 
Increased oxidative stress might contribute towards accelerated autophagy in mutant brains. 
Remarkably, hypoxia plays a role in the development of Alzheimer’s disease, but whether 
NCL patients present hypoxic brain tissues is not known. We envisage that either oxidative 
stress or hypoxia in CG12163 mutants might lead to excessive autophagy. Excessive 
autophagic activity has been proposed to lead to autophagic stress, imbalanced autophagic 
flux and eventual cell death of neurons (Lee, 2012). Further evidence of autophagic stress is 
our finding that transcription of the autophagy gene Atg8 is increased in CG12163 mutant 
brains. However, our results suggest that the autophagic changes are likely a consequence, 
rather than a cause of the neuronal phenotypes observed in CG12163 mutant brains. It will be 
interesting to examine brain tissues of NCL patients to assess whether indeed they are 
subjected to hypoxic or oxidative stress, and to investigate the role of autophagy in the 
development of NCL disease.  
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10 SUPPLEMENTARY DATA 
Table S1: List of genes identified in the Vps25RNAi primary screen 
 
Suppressors Enhancers 
CG10083 ndl 
CG10147 Rpn6 
CG1021 Hip1 
LanA CG10973 
mbc dgrn 
alphaKap4 CG11241 
eyg CG11255 
Itp-r83A CG11267 
toe Rcd5 
Vps36 VhaM9.7-c 
Chro Nc73EF 
Fur1 vps2 
Madm mei-P22 
Sap130 Fit1 
Ssl1 ImpL2 
slif Vha55 
CG11253 bin 
mael disp 
ste14 aralar1 
Syx13 TER94 
Mul1 aur 
Abd-B ClC-a 
Ras64B twin 
CG11876 Jupiter 
hyx sals 
CG11997 Pc 
CG12163 VAChT 
tipE sav 
pav Not1 
btz CG3764 
CG13025 Baldspot 
mats Abl 
stg Pcaf 
tkv Csk 
Bub1 plx 
CG14128 bnl 
CDase lack 
Chd64 FBgn0011666 
ens Irbp 
RfC4 ClC-c 
mas wkd 
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CG17360 sds22 
CG17364 pll 
Lnk crb 
CG18404 lsn 
Wnt2 Sbf 
Mad1 CG6962 
sec8 Dic61B 
Tina-1 AP-50 
FBgn0016061 Rack1 
CG31145 CG7146 
Dscam3 CG7369 
repo hbs 
wry Mekk1 
CG32113 Fit2 
RhoGAP71E mrn 
l(3)76BDr sim 
SPoCk ran-like 
CG3339 sr 
U3-55K shrb 
Rim gro 
CG33970 Vps16A 
Rab26 CG8546 
okr wun 
jumu Shal 
CG4098 Ras85D 
l(3)73Ah brv1 
TFAM CG9775 
lqfR pinta 
Nedd4 CG7023 
Gap69C CG31100 
cnc mgr 
scrib VhaM8.9 
Irk2  
XNP  
CG4553  
hh  
CG4849  
Syx7  
l(3)72Dh  
Pgm  
Pli  
Zn72D  
CG5235  
Taspase1  
loco  
Taf4  
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cln3  
Prm  
Arr2  
cdi  
Pep  
sec10  
Apc2  
Rfx  
Dcr-2  
FBgn0001168 
CG6498  
AGO1  
oa2  
Saf-B  
Nrx-1  
Mkrn1  
htl  
CG7255  
byn  
AGO2  
gwl  
CG7804  
PP2A-B'  
CG7963  
Su(z)12  
Vps45  
Rab8  
ATPCL  
cg  
lqf  
sec63  
wun2  
Fps85D  
Gmd  
Hsc70-1  
by  
Dab  
Nrt  
pum  
CG32109  
Aos1  
CG33293  
CG17184  
trc  
 
 
 
